University of Texas at El Paso

ScholarWorks@UTEP
Open Access Theses & Dissertations
2021-05-01

Engineering Cardiac Tissues with Three-Dimensional Bioprinting
for Biomedical Applications
Matthew Alonzo
University of Texas at El Paso

Follow this and additional works at: https://scholarworks.utep.edu/open_etd
Part of the Biomedical Commons

Recommended Citation
Alonzo, Matthew, "Engineering Cardiac Tissues with Three-Dimensional Bioprinting for Biomedical
Applications" (2021). Open Access Theses & Dissertations. 3212.
https://scholarworks.utep.edu/open_etd/3212

This is brought to you for free and open access by ScholarWorks@UTEP. It has been accepted for inclusion in Open
Access Theses & Dissertations by an authorized administrator of ScholarWorks@UTEP. For more information,
please contact lweber@utep.edu.

ENGINEERING CARDIAC TISSUES WITH THREE-DIMENSIONAL BIOPRINTING FOR
BIOMEDICAL APPLICATIONS

MATTHEW ALONZO
Doctoral Program in Biomedical Engineering

APPROVED:

Binata Joddar, Ph.D., Chair

Felicia S. Manciu, Ph.D.

Munmun Chattopadhyay, Ph.D.
Sylvia L. Natividad-Diaz, Ph.D.

Stephen L. Crites, Jr., Ph.D.
Dean of the Graduate School

Copyright ©

by
Matthew Alonzo
2021

Dedication

This one’s for me.
-M.A.

ENGINEERING CARDIAC TISSUES WITH THREE-DIMENSIONAL BIOPRINTING FOR
BIOMEDICAL APPLICATIONS
by

MATTHEW ALONZO, M.S.

DISSERTATION

Presented to the Faculty of the Graduate School of
The University of Texas at El Paso
in Partial Fulfillment
of the Requirements
for the Degree of

DOCTOR OF PHILOSOPHY

Biomedical Engineering
THE UNIVERSITY OF TEXAS AT EL PASO
May 2021

Acknowledgements
I would like to acknowledge the mentorship and guidance of my advisor Dr. Binata Joddar,
the faculty and staff in the Department of Metallurgical, Materials, and Biomedical Engineering,
as well as those at the Border Biomedical Research Center at The University of Texas at El Paso
(UTEP). I would further like to acknowledge the help of Dr. Chattopadhyay’s lab at Texas Tech
University Health Sciences Center El Paso (TTUHSC), Dr. Ito’s lab at RIKEN in Japan, Dr. Sugg’s
lab at The University of Texas at Austin, and Dr. Willerth’s lab at University of Victoria (UVIC),
for their assistance and expertise. I also thank my peers and lab mates in the Inspired Materials
and Stem-Cell-Based Tissue Engineering Laboratory (IMSTEL) at UTEP. Additionally, I
appreciate my committee members for their service, mentorship, and input in making me a better
scientist/engineer. In terms of academic funding, I would like to acknowledge the Gates
Millennium Scholarship Program, National Science Foundation Partnership for Research and
Education in Materials, Patrick E. and Eloise B. Fellowship, NSF grants #1828268, # 1927628,
#1854008, NIH SC1 grant #1SC1HL154511-01, and NIH 1SC2HL134642-01 for supporting me
throughout my doctoral studies. I am humbly grateful for you all. Thank you for molding me into
a better researcher and engineer throughout the last couple of years and making this dissertation
possible.

v

Abstract
The role of a biomedical engineer is to solve unmet health-related needs that face society.
For the past couple of decades, heart disease (HD) has remained the leading cause of mortality and
morbidity worldwide. The disease is characterized by various pathologies that affect the heart.
Indeed, malfunction of one of the body’s most vital organs is bound to manifest poor health and
even death in patients. Despite advances in medicine and technology, heart disease continues to
be prevalent and diminishes the quality of life for many around the world. Certainly, there exists
a need for developing new tools to better understand and treat HD. Tissue engineering cardiac
tissues in-vitro offers an alternative, useful platform to study diseases and navigate towards
generating biologically relevant artificial tissues for clinical translation.
Tissue engineering combines biomaterial scaffolds, cells, and construction methods to
grow viable tissues in-vitro and in-vivo. Advent of three-dimensional bioprinting has allowed for
creation of living tissues that mimic the geometries and physiologies of native tissues. In
accordance to the principles of this field, this work aims to exploit the benefits afforded by
extrusion-based 3D-bioprinting to engineer viable cardiac tissues in-vitro for biomedical
applications. Studies include development of a furfuryl-gelatin-fibrinogen bioink that was
crosslinked enzymatically by the conversion of fibrinogen into fibrin and with photo-oxidation
with visible light. Cardiomyogenesis was observed in bioprinted constructs, characterized by the
coupling of human cardiomyocytes and fibroblasts. Furthermore, cells within bioprinted constructs
showed characteristic cardiac biomarkers and preferred cellular organization in the direction of
bioprinted filaments. In another investigation, a murine animal model was adopted to develop a
method of cryo-inducing myocardial infarction in-vivo. A reproducible zone of necrotic
myocardium that resembled many of the histopathological characteristics of the naturally-
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occurring MI was produced using a cryo-probe. Developing protocols for generating controlled
infarcts on demand provide a beneficial in-vivo model for future implantation of 3D-bioprinted
cardiac grafts. Development of 3D-bioprinted constructs was further explored through the
development of a scaffold able to culture endothelial cells, a third major cell type found in the
heart. The scaffold was tailored to house all three heterogenous cardiac cell types for future study
of microgravity-induced cardiac atrophy during spaceflight. Finally, modulation of cardiomyocyte
physiology was probed in response to variation in hydrogel mechanical composition. A hydrogel
system was adopted to mimic various developmental stages of the heart. Mechanical properties of
gels were optimized to mimic stiffness of embryonic, physiologic, and fibrotic cardiac tissue. CMs
cultured in softer gels showed enhanced cellular networking and alignment within hydrogel
scaffolds as compared to those cultured to stiffer ones. Results from this work give insight into
biomaterial selection for three-dimensional culture and their effect on the construction of cardiac
tissues in-vitro.
Generating viable cardiac tissues on-demand with three-dimensional bioprinting has the
potential to greatly benefit society and provide an extra tool to understand and battle heart disease.
Bioprinting creates architecturally similar tissues to those of the native heart, as well as provide
physiologically responsive platforms for disease modeling and pharmaceutical testing. They
further hold potential to be used for as grafts to replace necrotic or fibrotic myocardium. Work
from this dissertation sets a foundation for further development of 3D-bioprinted cardiac tissues
in-vitro.
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Chapter 1: Introduction and Declaration of Specific Aims
1.1. BIOMEDICAL ENGINEERING: AN INTERDISCIPLINARY FIELD
Biomedical engineering is an interdisciplinary field that uses engineering principles to
research and develop medical technology to help solve some of the biggest healthcare problems
facing society [1]. One of the main goals of a biomedical engineer is to understand, modify, or
control biological systems as well as design and manufacture products that can monitor
physiological functions and assist in the diagnosis and treatments of patients [1]. The field has
progressed from being focused on developing medical instruments in the mid 1900s to a breadth
of other activities [1]. A list of some of these activities are laid out in Table 1.1 below with topics
explored in this dissertation highlighted in boldface. Besides the technology developed, one of the
greater benefits of biomedical engineering is the identification of impediments and unmet needs
of our present healthcare system [1]. Thus, biomedical engineers provide the tools and techniques
that make our healthcare system more effective, efficient, and improve the quality of life for
patients [1]. With the role of a biomedical engineer in mind, this dissertation aims to understand
and tackle a huge burden that currently faces today’s global society: heart disease.
Table 1.1: Various concentrations of biomedical engineering with some principles used in this
dissertation in boldface.
Genres of Biomedical Engineering
Drug Design and
Biomechanics
Biomaterials
Tissue Engineering
Delivery
Regenerative
Medicine and Cell
Therapies

Personalized
Medicine, Genomics,
and Proteomics

Prosthetics

Telemedicine

Biosignals and
Biosensors

Physiologic and
Disease Modeling

Medical Robotics

Biomimetics

Clinical Engineering

Medical and
Bioinformatics

Biotechnology

Medical Imaging

1

1.2. HEART DISEASE: A GLOBAL HEALTH PROBLEM
According to the United States’ Centers for Disease Control and Prevention [2], and the
World Health Organization [3], heart disease has remained the leading cause of death in the global
population for the last couple of decades [4, 5]. Cancer and stroke trail behind in second, on the
American and international stages, respectively [2, 3]. Heart disease, a type of cardiovascular
disease, is the term given to myriad disorders that affect the heart and its blood vessels [5, 6].
Examples of heart disease include coronary artery disease, arrythmias, and malfunctions of the
valves, as depicted in Illustration 1.1 [6].

Illustration 1.1: Many pathologies are associated with heart disease, with coronary artery
disease being the most prevalent. This illustration was obtained from [7].
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Indeed, malfunction to one of the most vital organ systems in our body is bound to manifest
poor health, even death, in patients. Ischemic heart disease is the largest contributor to the global
death toll from all forms of heart disease [8]. It accounts for about 1.72% of the world population
[8]. As its name suggests, ischemic heart disease is characterized by occlusion of the blood vessels
that supply the organ with oxygen-rich blood. The occlusion is most commonly caused by the
accumulation of fat deposits or a thrombus within an artery, usually one of the coronary arteries
of the heart [9]. As circulation ceases, cardiac cells in the thick myocardial wall begin to experience
hypoxia and begin to asphyxiate[10]. This event where the muscle of the heart is suffocated and
dies due to the blockage of vessels is known as a myocardial infarction (MI), more commonly
referred to as a heart attack [10]. This phenomenon is represented in Illustration 1.2. Unfortunately
for cardiac myocytes, the main cell-type of the myocardium, they do not possess the capacity to
regenerate unlike other tissues in our body [11]. Yet, the heart still has a mechanism in place to try
to heal itself and attempt to restore homeostasis.

Illustration 1.2: Myocardial infarction is characterized by occlusion of the heart’s arteries by
plaque or a blood clot that causes death of the myocardium. This illustration
was obtained from [12].
3

Cardiac repair after acute myocardial infarction begins with inflammation to the
myocardium [13]. During this phase inflammatory cells are recruited and infiltrate the damaged
heart wall [13]. Enzymes, such as matrix metalloproteases, begin digesting the extracellular matrix
(ECM) to free the cellular debris caused by hypoxia-induced apoptosis [13]. Macrophages then
begin to remove the cellular debris loosened from the digested ECM [13]. This process usually
lasts for a couple of days, after which inflammation wanes and neovascularization and the
reparative phase begin [13]. During this stage that lasts for about two weeks, new vasculature
begins to form, and fibroblasts begin depositing a thick collagenous scar to replace the damaged
myocardium [13]. Weeks after acute MI, a complete scar has formed on the myocardial wall [13].
Stages of cardiac repair are summarized inn Illustration 1.3. Due to the poor contractile properties
of the scar, the heart’s pumping efficiency is impeded as it has to overcompensate to carry the dead
weight contributed by the robust collagen deposit [14]. Over time, the vitality of organ dwindles
and the organ’s ability to function, and leads to heart failure [14]. Heart failure is when the heart
cannot pump enough blood to meet the body’s demands [14]. Recalling from Illustration 1.1, heart
failure is another form of heart disease. Therefore, if the onset of acute myocardial infarction does
not kill you, you are still at further risk of developing heart failure and dying from that. Heart
disease is consequentially a serious biomedical area of interest where much more can be done to
reduce the damage caused by this disease.
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Illustration 1.3: The three stages of myocardial repair after injury. This figure was reproduced
with permission from [15].
Current treatments to mitigate the effects of myocardial infarction range from lifestyle
changes to invasive surgeries [16]. If the heart attack is mild, patients are advised to exercise once
recovered in order to strengthen their heart [16]. Additionally, removing any stress, drugs, alcohol,
and a cleaning up one’s diet can lower one’s risk of inducing an MI [16]. Furthermore, physicians
also analyze the cause of the infarction by locating the occluded cardiac blood vessel [16]. If the
vessel can be cleared by a catheter, the artery regains perfusion ability [16]. Sometimes, a meshlike metal stent is inserted to hold the target vasculature dilated for blood flow to occur [16]. If the
artery is unable to be cleared for reperfusion, a bypass surgery is performed in which vasculature
from another part of the body, usually the great saphenous vein, is harvested and connected in such
a way that reroutes blood flow from the site of blockage to the other end of the blocked artery [16].
This, as its name states, bypasses the occlusion to deliver blood flow to myocardial tissue. A visual
summary of these treatments can be referenced in Illustration 3.2. While a stent and bypass
surgery certainly reperfuse the myocardium, they don’t address whatever damage has already been
done to the cardiac muscle.
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Patients who develop a weakened heart due to the added stress on the heart from the
collagen scar (i.e. develop heart failure), will require outside reinforcement in pumping to reduce
its workload. For these people, a ventricular assistive device (VAD) is implanted [16]. While
VADs unburden the heart from overworking itself, they produce some burdens of their own. They
may cause blood clots, require open heart surgery, sometimes have device malfunctions, and may
cause heart failure anyway [17]. Thus, patients may be prescribed blood thinning medications
which could cause complications if the patient were to bleed [17]. One of the last options for most
patients progressing toward heart failure is a heart transplant [16]. There are more than 7,300
people in the United States alone that are currently on a list for a heart transplant, with only 2,000
transplants actually performed per year [18]. Clearly the availability of vital organs cannot keep
up with the rate of people who need one [18]. Furthermore, even if patient is lucky enough to
obtain a vacant heart, they still run the risk of having their immune system reject the organ [19].
Physicians therefore prescribe immunosuppressive drugs to reduce this possibility; however, there
is added risk of the patient succumbing to another illness [19]. These immunosuppressive drugs
are prescribed for life, and therefore the immune system would be too weak to fight off any foreign
agents into the host’s body [19]. These treatments are currently our limit in combating heart disease
as it relates to ischemic heart disease and heart failure. Certainly, there is room for improvement
in combating the disease responsible for claiming the most human lives. Tissue engineering offers
an alternative, potentially better solution.
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1.3. TISSUE ENGINEERING: A POTENTIAL SOLUTION
Tissue engineering is sub-genre of biomedical engineering whose central dogma is to find
innovative ways to design viable tissues substitutes that restore, maintain, or improve tissue or
organ function by combining cells, scaffolding material, nutrients, and stimuli [20]. Its principles
were first introduced to the world in 1993 and can be used to design biological tissues of all types
[21]. One of the ultimate goals of tissue engineering is to be able to produce complete organs or
tissues [20]. In terms of cardiac tissue engineering, the idea to regenerate the necrotic myocardium
post-MI began with the notion of injecting a suspension of cells into the infarct site. It was found
on numerous occasions, however, that little of the injected cells were retained in the heart [22, 23].
One could deduce this since the heart is the most dynamic organ in the body beating at 60-100
beats per minute [23]. Even for injected heart cells that were able to stay in the myocardium, their
viability remained low [24]. It was later found the use of a biocompatible scaffolds offered cells
an architecture to mold themselves on while simultaneously increasing the retention of cells [25].
Various types of materials have been used for scaffolds ranging from decellularized tissues to
hydrogels that have been arranged in particular manner [26]. For example, in the process of
electrospinning, hydrogels are spun using an electric field where scaffold properties such as
porosity can be controlled [27]. As technology developed, the advent of bioprinting introduced a
new method where scaffolding material and cells could be fashioned into predetermined
geometries and has been used to print architecturally relevant tissues of all kinds [21, 28]. In the
following work, I aim to combine biomedical engineering and current state-of-the-art tissue
engineering principles by exploiting the benefits of 3D bioprinting to develop three-dimensional
tissues and disease models that can be utilized by the scientific community for biomedical
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applications. To guide me in the development of a cardiac tissue platform, the following questions
are posed:

In-Vitro:
1. Can we develop a bioink scaffold and design to mimic in-vivo cardiac tissue?
2. What cell types do we essentially encapsulate to build a cardiac tissue on a chip?
3. Can this tissue on a chip be used to model cardiac fibrosis?
In-Vivo
4. As a long-term objective for implantation of cardiac tissue platform, can we make a
simple model to mimic myocardial infarction in larger rodent models?

To answer these questions, the following specific aims and hypothesis have been laid out as a
general outline for work covered in this dissertation:

1.4. HYPOTHESES AND SPECIFIC AIMS
The central hypothesis of this dissertation is three-dimensional bioprinting to engineer
cardiac tissues in-vitro would afford constructs that mimic the architecture and physiology found
in native heart tissues.
1.4.1. Specific Aims 1A & 1B
Specific Aim 1 is split into two main components. The first component, Specific Aim 1A,
will examine the feasibility of bioprinting a three-dimensional cardiac patch using a lab-developed
bioink for potential application as a graft for patients who have suffered from cardiac necrosis and
scarring after myocardial infarction. We hypothesize the addition of fibrin to an existing lab8

developed bioink composition would yield a composite structure that would match the elastic
modulus of native cardiac tissue. We further expect that this enhanced scaffold would lead to
cardiomyogenesis by promoting heterocellular coupling between human cardiomyocytes and
fibroblasts, a phenomenon that occurs in cardiac tissue in-vivo. Once feasibility of the construction
of such a graft has been established, Specific Aim 1B intends to develop and optimize a cryoinduced myocardial infarction protocol in a rat that will serve as a model for future implantation
of the 3D bioprinted cardiac patch developed in Specific Aim 1A. In using a cryoprobe, we believe
we can successfully induce a zone of tissue necrosis that histologically mimics the pathological
outcomes of the naturally-occurring myocardial infarct.
1.4.2. Specific Aim 2
Specific Aim 2 targets to design and optimize a scaffold that will promote vascularization
in cardiac tissues engineered in-vitro using three-dimensional bioprinting. Based on our
preexisting 3D bioprinted cardiac tissue model with heterocellular coupled cardiomyocytes and
fibroblasts, we hypothesize the introduction of a third major cardiac cell type such as endothelial
cells, will serve as a more complete cell model system.
1.4.3. Specific Aim 3
Specific Aim 3 studies the effect of varying scaffold composition on cardiomyocytes and
will reveal important insights into fibrosis of the heart. We hypothesize culturing cardiomyocytes
in a 3D scaffold with stiffness’s that mimic the different developmental stages of cardiac tissue
will yield important insights into normal tissue development and also pathological modulation of
disease progression in cardiac tissue.
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Chapter 2: Methodology
In order to meet the specific aims of this dissertation, the following scientific methods and
theory will be applied to meticulously approach in the construction and subsequent analysis of
engineered cardiac tissues in the laboratory setting. A brief survey for each of the methods used is
elucidated along with their significance in this work.
2.1. THREE-DIMENSIONAL BIOPRINTING
2.1.1. Types of Bioprinting
As briefly mentioned, bioprinting is the current state of the art method to produce viable
tissues in-vitro as the deposition of biomaterial, cells, and nutrients can be spatially controlled.
Bioprinting is an additive manufacturing (AM) technique that enables the creation of biological
structures using a combination of viable cells, nutrients, and biomaterials called “bioinks” which
serves as the printing material [29, 30]. Bioprinting can effectively produce scaffolds possessing a
suitable microarchitecture, providing mechanical stability, and promoting cell ingrowth while also
accounting for the impact of manufacture on cell viability [30]. The biggest advantage of
bioprinting provides control over the homogenous distribution of cells post-fabrication, as cells
are deposited in a layer-by-layer fashion during the printing [31]. Homogenously distributed cellladen scaffolds have exhibited integration with the host tissue at a faster pace, lower risk of
rejection and uniform tissue growth in vivo [32].
A main objective of bioprinting is to provide a more feasible alternative to autologous and
allogenic tissue implants that do not invoke an immune reaction and also can replace the use of
animal models for the study of disease pathology and drug testing [32, 33]. The three most common
types of 3D printers being used presently are inkjet-based, extrusion-based and laser-assisted 3D
printing. A summary of differences can be seen in Table 2.1 while a visual description of each in
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Illustration 2.1. Inkjet bioprinters, also known as drop-on-demand printers, utilize a non-contact
technique that involves thermal, piezoelectric, or electromagnetic forces to expel successive drops
of bioink onto a substrate, replicating a CAD design with a printed tissue [33]. Extrusion based
models make use of mechanical or pneumatic forces for dispensing the bioink in continuous
streams unlike the discrete droplets deposited by inkjet printers [33]. Laser-assisted 3D bioprinting
technology directs laser pulses through a “ribbon” containing the bioink, supported by a titanium
or gold layer capable of absorbing and subsequently transferring energy to the ribbon [33]. The
bioink and cells suspended on the bottom of the ribbon cause a high-pressure bubble to form. This
bubble eventually propels discrete droplets onto the receiving substrate that lies just beyond the
ribbon, upon vaporization by the laser pulse. This step is repeatedly performed to functionally
create the 3D structures [33].
Table 2.1: Comparison between inkjet-based, extrusion-based and laser-assisted printing
techniques. This table was obtained from [34].
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Illustration 2.1: Various methods of bioprinting and their method of function. Extrusion
bioprinting will be used This figure was taken with permission from [33].
2.1.2. Hydrogels/Bioinks
Hydrogels are polymeric materials, of natural or synthetic origin, characterized by their
ability to retain a large amount of water within their porous three-dimensional structure [35]. Their
excessive hydrophilicity allows them to hold up to 90% water which can be exploited to
encapsulate and deliver therapeutic agents such as cells, growth factors. DNA, and drugs [35]. The
chemical structure of the molecular backbone can be tailored to respond to eternal stimuli such as
temperature, pH, electric fields, light, solvent composition, ionic strength, salt type, pressure, and
biomolecules [35]. Furthermore, myriad hydrogels are biocompatible, making these materials of
particular interest for application in pharmaceuticals, biosensing, microfluidics, drug delivery, and
tissue engineering [35]. As a biomedical engineer, these biomaterials are attractive sources to
implement as scaffolds to construct viable three-dimensional tissues.
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When constructing tissues, hydrogels provide a three-dimensional scaffold where large
amounts of cells are allowed to migrate and facilitate tissue formation. There are several types of
hydrogels that have been used to engineer various tissues. Natural hydrogels include those found
in nature in plants and animals, while synthetic ones are created in a laboratory. Each material has
their own crosslinking mechanism that allows it to gel and maintain its shape, thereby entrapping
cells and other payloads. The following is a brief survey of hydrogels used in this work:
2.1.2.1. Fibrin
Fibrin is a versatile biopolymer, with excellent potential for tissue regeneration and wound
healing [36]. It is a fibrous glycoprotein that can be found in the plasma fraction of blood and
forms one of the key components in the blood clotting process, playing a crucial role in the
prevention of haemorrhage and the promotion of wound healing [36]. It results from thrombinmediated cleavage of fibrinogen as part of the coagulation cascade [36]. Fibrin serves as a transient
wound healing matrix following an injury and facilitates the growth of fibroblasts to enhance cell
motility in wound healing [36]. Fibrin exhibits superior biocompatibility, because fibrin matrices
contain sites for cellular adhesion. Fibrin by itself, or in combination with other biomaterials, was
employed as a biological scaffold to promote stem or primary cells to regenerate. Currently, fibrin
has been employed for a variety of clinical applications, including its usage as a medical-grade
sealant or “tissue glue.” In terms of tissue engineering applications, it is known to promote
vascularization, thus us a popular biopolymer [36]. Wide use of fibrin, its natural origin, and
biocompatibility make it an attractive choice for constructing three-dimensional cardiac tissues,
especially ones that aim to be applied as grafts.
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2.1.2.2. Gelatin
Gelatin is hydrolysed collagen. It is extensively used in tissue engineering of tissues as it
is economical and is derived from one of the most ubiquitous components of native extracellular
matrices. It is primarily composed of glycine, proline, and 4-hydroxy proline residues generated
by the partial hydrolysis of collagen extracted from the skin, bones and connective tissues of pigs
and fish]. Gelatin makes for an excellent scaffold for cell culture as it is biodegradable,
biocompatible, and possesses RGD (Arg-Gly-Asp) moieties for cell adhesion, elongation,
migration, and alignment. The chemical structure of gelatin is shown in Illustration 2.2.
Crosslinking of gelatin can occur in multiple ways. Strands of gelatin become entangled as
temperature decreases, thus giving the material rigidity. Thus, one method of crosslinking gelatin
is through thermal methods. It can also be crosslinked and modified by adding other materials that
significantly enhance its biochemical and mechanical properties. Gelatin has been crosslinked in
prior studies via disulphide crosslinking [81], photo crosslinking [82, 83] and enzymatic
crosslinking [84, 85] among others. Due to high collagen in the native cardiac extracellular matrix,
this collagen-derived biopolymer is an attractive candidate for three-dimensional cardiac tissue
engineering.

Illustration 2.2: The chemical composition of gelatin is a linear backbone of amino acids. The
arginine-glycine-aspartic acid sequence in gelatin allows for cell adhesion.
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2.1.2.3. Alginate
Another biopolymer naturally-derived from seaweed is alginate. Alginates become easily
crosslinked through the introduction of divalent cations, usually Ca2+. Due to their ability to
absorb large amounts of water and their crosslinking density can be easily tuned, this hydrogel has
demonstrated extensive applicability as cell-laden scaffolds. Alginate is a linear polysaccharide
and is composed of (1,4)-linked β-d-mannuronate (M) and α-l-guluronate (G) residues in varying
contents and distributions along the polymer. Alginate can be more readily crosslinked as more G
residues are present in the molecule along increasing Ca2+, as seen inn Illustration 2.3.. Benefits
of alginate hydrogels are gelation at physiological conditions, transparency for microscopic
evaluation, and retention of a homogenous, porous network formation that allows diffusion of
nutrients and removal of waste. Although alginate is a great biomaterial to provide a threedimensional culture environment, it cannot house cells within its networked structure alone.
Alginate is not bioactive; therefore, cells cannot directly attach to its structure. For this reason,
alginate is usually combined with other biomaterials that provide points for cell adhesion such as
gelatin, fibrin, and Matrigel.

Illustration 2.3: When alginate becomes crosslinked with divalent cations, such as Ca2+, two
guluronic acid moieties create an “egg-box” shaped link. This figure was taken
with permission from [37].
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2.1.3.4. Matrigel
Matrigel is derived from the basement membrane of Engelbreth-Holm-Swarm tumors in
mice [38]. At physiologic temperatures (37oC), the soluble derivative of the basement membrane
forms a three-dimensional gel that supports cellular differentiation and growth due to the rich
growth factors it provides [38]. Due to its rich protein content, Matrigel provides an excellent
surface for cells to attach [38]. Matrigel is enriched with laminin, collagen type IV, perlecan, and
entactin [38]. One downfall to Matrigel, is that it is a not well-defined substance where the relative
concentrations of its individual constituents may vary, and can therefore produce variability within
experiments [38]. Furthermore, due to its potential tumorigenicity and murine origins, Matrigel
cannot be used in humans [38]. However, it can be useful in scaffolds as a growth factor and
adhesion factor combination and has been widely used to study approaches in engineering muscle
and other tissues and to maintain stem cells in culture. Due to this ability to maintain cells in 3D
culture, Matrigel is used in Specific Aim 3.
2.2. MAMMALIAN CELL CULTURE
Of most importance in the construction of tissues in-vitro, is the ability to isolate and
grow mammalian cells in multiple types of environments. For cardiac tissue engineering, and for
the purposes of this dissertation, human AC16 cardiomyocytes, human adult fibroblasts, and
human dermal microvascular endothelial cells were used to manufacture 3D tissues. In the
following sections, I elucidate the difference of culturing cells in two and three dimensions, and
elaborate on the cells used in this work. Commonly used equipment for cell culture includes a
biosafety cabinet, centrifuge, incubator, water bath, and inverted microscope as displayed in
Illustration 2.4.
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Illustration 2.4: Commonly used equipment for cell culture experiments included use of a
biosafety cabinet, centrifuge, incubator, inverted microscope, and water bath.

2.2.1. Two- and Three-Dimensional Cell Culture
Cell-based assays play a crucial role in drug discovery and the development process.
Mammalian cell culture offers a well-defined platform for the investigation of cell and tissue
physiology and pathophysiology outside of the organism. For over a century, traditional 2D cell
culture was used in drug discovery. In 2D cell culture, cells are allowed to grow on flat dishes
optimized for cell attachment and growth [39]. 2D cell culture models are still extensively
employed presently to test cellular drug responses to drug candidates and have contributed to the
17

increased understanding of drug mechanisms of action. However, the main limitation of this
technique is that the cells are cultured as a monolayer on flat petri dishes or flasks which provide
a stiff platform, offering unnatural growth kinetics and cell attachments. Therefore, the natural
microenvironments of the cells are not represented in their entirety [39]. Recently, significant work
by researchers have produced improvements in the form of better in vitro cell culture models
resembling in vivo conditions in the form of three-dimensional cell cultures which have
demonstrated that they can effectively mimic tissue physiology in multicellular organisms. While
traditional monolayer cultures are still predominant in cellular assays used for high-throughput
screening 3D cell cultures techniques for applications in drug discovery have made rapid
advancements[39].

2.2.2. AC16 Human Cardiomyocyte Cell Line
AC16 human cardiomyocyte cell line was derived from the fusion of primary adult human
ventricular heart tissue cells with SV40 transformed, uridine auxotroph human fibroblasts, lacking
mitochondrial DNA [40]. Following the use of a uridine-free medium as a selection for the removal
of unfused fibroblasts, the remaining fused cells were subcloned and screened for the presence of
SV40 large T-ag, β-myosin heavy chain (βMHC) and connexin-43 (Cx-43) [40]. Therefore, these
cells are similar in their physiological behavior to most human primary cardiomyocytes and
possess the ability to enter the cell cycle making them a robust cardiac myocyte cell model useful
for multiple experiments.
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2.2.3. Human Fibroblasts
Amongst the many heterogenous cell-types resident within the heart, the human cardiac
fibroblast (Cell Applications Inc.) is the most prevalent. Due to their abundance in myocardial
tissue, and to make a more relevant artificial biological tissue that resembles native tissue, the
human cardiac fibroblasts make for an interesting cell type to include within bioprinted engineered
constructs. This cell type has been studies extensively inn literature such as in the determination
of the electrical coupling between CM-CF pairs, studies where mechanical stretching is an
important parameter in the release of certain growth factors, as well as other cardiac-related
studies. Thus, the utilization of this cell to include in nan artificial cardiac tissue system would
more accurately mimic natural tissues.
2.2.4. Human Dermal Microvascular Endothelial Cells
Human dermal microvascular endothelial cells (HDMECs; Sigma Aldrich) are primary
cells as they are derived directly from native tissue [40]. Specifically, HDMECs are isolated from
the dermis of juvenile foreskin, as dermal tissue contains blood and lymphatic capillaries [40].
HDMECs comprise Blood and Lymphatic Microvascular Endothelial Cells. Both have a common
origin and can be identified by several markers, according to the manufacturer [40]. Endothelial
cells are a major cell type within the heart that form the vasculature within the myocardium. Invitro, these cells have been known to form microvascular channels within hydrogel systems [40].
Thus, this cell was thought to be a useful model of endothelial cell to include within experiments.

2.3. MATERIAL CHARACTERIZATION OF HYDROGELS
2.3.1. Scanning Electron Microscopy
Scanning Electron Microscopy (SEM) is an imaging technique that generates micrographs
of a sample by scanning its surface with a beam of electrons that interact with the atoms
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constituting the sample and produce various signals that contain information about the surface
topography and composition of the sample under study [41]. The electron beam is scanned in a
raster scan pattern, and the beam position is coupled with the intensity of the detected signal to
help generate the image [41]. The most common SEM mode works with secondary electrons that
are emitted by atoms excited by the electron beam and are captured by the detector. SEM has been
exhaustively employed to characterize biological scaffolds in an attempt to study their
morphologies and pores.
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Illustration 2.5: A Hitachi
2.3.2. Fourier Transform Infrared Spectroscopy
The Fourier Transform Infrared Spectroscopy (FTIR) is a highly sensitive, non-destructive
technique used to characterize and identify organic molecules. The interaction of the infrared
radiation with the sample molecules causes the chemical bonds to stretch, contract or bend
resulting in the absorption of infrared radiation in a specific wavenumber range, regardless of the
structure of the rest of the molecule. An FTIR spectrometer obtains the infrared spectra by
collecting an interferogram of a sample signal with an interferometer, which can measure all
infrared frequencies simultaneously. The spectrometer then proceeds to acquire and digitize the
interferogram and perform the Fourier Transform function, generating the spectrum. Since every
functional group has a characteristic vibrational frequency and wavenumber, the analysis of the IR
spectrum will be helpful in identifying the different functional groups present in the sample.
2.3.3. Rheology
Rheology encompasses the study of flow of matter and is employed to estimate the
viscoelastic behaviour of the hydrogel materials serving as tissue engineering scaffolds.
Viscoelasticity refers to the property of materials to exhibit both viscous and elastic behaviour
when they undergo deformation. Rheology is studied with the help of a rheometer that conducts
small deformation experiments, typically in the form of small amplitude oscillatory shear
measurements on the sample. Small deformations are used ensuring that the experiment is carried
out within the linear viscoelastic region of the material. This implies that the properties of the
hydrogel are independent of the magnitude of the applied stress or strain and the results are solely
based on the material tested and are not impacted by the experimental variables.
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The key parameters that can be determined by rheology are the storage (G’) and the loss
(G’’) moduli. The storage modulus G’ is a measure of the stored deformation energy or the
stiffness component of the material and the loss modulus G’’ measures the energy dissipated or
the flowability of the material during the shearing process. The storage and loss moduli therefore
serve to describe solid-like and liquid-like material properties of hydrogels, respectively. It was
established that if G’>G” then samples behave more like an elastic solid and if G’’>G’, the sample
behaves like a viscous liquid. An Anton Paar MCR 92 rheometer with a 25 mm parallel plate
geometry (Illustration 2.6) was used for rheometric analysis of hydrogels.

Illustration 2.6: Anton Paar MCR 92 rheometer with a 25 mm parallel plate geometry was used
for rheometric analysis of hydrogel samples in this work.
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2.4. PROBING CULTURED CELLS AND TISSUES
2.4.1 Cell Viability (Live/Dead) Assay
One method to visually determine cell viability is through the implementation of a
Live/Dead assay, in which two molecular fluorescent dyes can be introduced to a culture of cells
to probe for two well-known parameters of cellular viability - intracellular esterase activity and
integrity of the plasma membrane [42]. In general, live cells exhibit intracellular esterase activity.
The cell-permeable dye calcein AM is converted from its nonfluorescent form to a fluorescent
configuration by exploiting the enzymatic activity within the cell [43]. As such, calcein AM is
made to emit a green fluorescence of ~515 nm when excited with light of ~495 nm in live cells
that are able to convert the dye into its active form. In addition, because the dye is polyanionic, it
is easily retained within the cell. Nonviable cells are visualized with ethidium homodimer-1 (EthD1). This dye is made optically active by binding to nucleic acids within the cell. It is nonpermeable
to the cell’s lipid bilayer, and can therefore only enter the cell if the wall is ruptured. A red
fluorescence is observed at ~635 nm when excited with ~495 nm light.
2.4.1 PKH26, PKH67, and CellTrace Violet
PKH26 red fluorescent dye used for general cell membrane labeling [44]. It has an
excitation wavelength of 551 nm and emission of 567 nm. It has been found to be useful in both
in-vitro and in-vivo cell tracking and proliferation studies [44]. Half-life for elution of PKH26
from labeled rabbit red blood cells is greater than 100 days. This enhanced stability is favorable
for long term in-vivo studies [44]. PKH67 green fluorescent dye is another membrane stain with a
long aliphatic tail. It’s excited with 490 nm and emits 502 nm light. The aliphatic tails of the dyes
form strong covalent bonds with the lipid bilayer of the intact cell membrane causing its long-term
retention [44]. CellTrace Violet is yet another dye that fluoresces violet as its name suggests. It
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has an excitation wavelength of 405 nm and emission of 450 nm. This dye also experiences longterm stability, even within proliferating cultures. These three cell membrane dyes were used to
track heterogenous cell types within hydrogel scaffolding.
2.4.2 Tissue Staining & Immunohistochemistry
Common stains for the examination of thin biological slices are Haematoxylin and Eosin.
The contrast is created when the Haematoxylin stains the nuclei blue while the Eosin turns the
cytoplasm and the extracellular matrix pink. These stains make the general layout and distribution
of cells stand out and provide a general overview of a tissue sample's structure making it easier to
differentiate between the nuclear and cytoplasmic parts of a cell.
2.5. MICROSCOPY
3.5.1 Brightfield Microscopy
Brightfield Microscope alternatively known as a compound light microscope is an optical
microscope that uses light rays to produce a dark image against a bright background in biological
studies for viewing fixed and live specimens, that have been stained with basic stains to show
contrast between the image and the image background. It is specially designed with magnifying
glasses known as lenses that modify the specimen to produce an image seen through the eyepiece.
The specimen is allowed to pass through a uniform beam of the illuminating light to ensure that it
can produce a contrasting image under a brightfield microscope through differential absorption
and refraction. The specimens to be imaged are prepared initially by staining to introduce colour
for easy contracting characterization. The coloured specimens will have a refractive index that will
differentiate them from the surrounding, presenting a combination of absorption and refractive
contrast. The specimen which is placed on a microscopic slide is viewed under oil immersion
or/and covered with a coverslip.
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3.5.2 Confocal Microscopy
Confocal microscopy is one of the most popular high-resolution imaging techniques widely
employed in tissue engineering. It affords an advantage over typical widefield microscopes in
terms of resolution of the final image [45]. Acquired images from widefield microscopes contain
sharp features for objects within the focal plane of the lens, but also produce blurred signals from
objects out of focus [45]. In confocal microscopy, light is reflected off the specimen and is
collected by an objective lens and passes through another pinhole via a beam splitter, before
reaching a photo multiplier where the image is formed [45]. A second pinhole in this arrangement
allows a large proportion of out-of-focus light to be rejected. The spatial resolution of a confocal
microscope is mainly controlled by the diameter of the pinhole and is diffraction limited. A
confocal microscope can observe optical sections thinner than 1 mm without physically having to
process samples [45]. When used in tandem with fluorescent microscopy, the spatial arrangement
of florescent molecules can be visualized with high precision.
3.5.3 Fluorescent Microscopy
Fluorescence microscopy is an imaging technique that is often used to monitor cell
physiology [46]. Various indicators that fluoresce can be tailored to target specific targets such as
protein epitopes, lipids, or ions [46]. Researchers are able to visualize the dynamics of tissue, cells,
individual organelles, and macromolecular assemblies. Specimens are illuminated with light of a
specific wavelength (or wavelengths). Fluorophores absorb incident light of a specific energy and
emit a photon of a different energy after a couple of nanoseconds [46]. This results in the emission
of light of longer wavelengths (i.e., of a different colour as compared to the absorbed light). This
process is called a Stoke shift [46]. Incident light is separated from the much weaker emitted
fluorescence by a spectral emission filter. The final result is the visualization of particular
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biomacromolecules of interest through their illumination. In the construction of cardiac tissues in
this dissertation, cells will be assessed using fluorescent dyes such as PKH26, PKH67,
CellTraceViolet, and through florescent antibody staining.
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Chapter 3: The 3D Bioprinted Cardiac Patch
Work presented in Chapter 3 was peer-reviewed and published in [47]. Therefore, a
majority of the images and information used in this chapter is based off the article cited above.
Permissions from publishers for figures used in this chapter can be found in Appendix A of this
dissertation. This chapter fulfills the objectives set out in Specific Aim 1A.
3.1. ABSTRACT
The goal of this study was to develop a novel bioink for extrusion-based bioprinting and to
bioprint a patch of cardiac tissue using human cardiomyocytes and fibroblasts. To accomplish this,
fibrin, a natural polymer found in the blood-clotting cascade, was added to a previously developed
in-lab bioink composition that consisted of a modified gelatin base that was crosslinked with
visible light. The addition of fibrin into the bioink formulation allowed for a bioprinted scaffold
that was able to retain its geometry after sequentially crosslinking the gelatin with visible light and
the conversion of fibrinogen into fibrin using a combination of thrombin and free calcium ions.
Characterization of the three-dimensional scaffold post-crosslinking revealed a porous,
interconnected microstructure and an elastic modulus that was in the range of native heart tissue.
Cells bioprinted with the developed bioink showed elongated morphology characteristic of cardiac
myocytes and fibroblasts, and cells arranged themselves along the direction of the extruded bioink
filaments. Furthermore, cells showed good viability within the scaffold and expressed distinctive
markers: fibroblasts with Fibroblast Specific Protein-1 and cardiomyocytes with Troponin-I and
Myocardin. Finally, tissue formation was seen to a higher degree, characterized by the coupling
of cardiomyocyte-cardiomyocyte and cardiomyocyte-fibroblast pairs through the intercellular
cardiac protein Connexin-43, in bioprinted samples versus controls where cells were mixed
randomly in bulk gels.
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Illustration 3.1: Graphical abstract of a 3D printed cardiac patch presented in Chapter 3 of this
dissertation. This figure was reproduced with permission from [47].
3.2. INTRODUCTION
As elucidated in Chapter 1, ischemic heart disease is the leading cause of death worldwide
[3, 48]. Ischemia usually occurs in one of the coronary arteries of the heart and is therefore
sometimes referred to as coronary artery disease [9]. Patients suffering from this condition have a
build-up of cholesterol and fatty plaque that is deposited along the circumference of the inner
vessel walls that perfuse oxygen-rich blood to the thick myocardium [9]. A variety of factors
increase the risk of an individual including, but not limited to, a sedentary lifestyle, smoking, drugs,
and an unhealthy diet [49]. Blood flow is essential for tissue survival, as it allows for exchange of
oxygen/carbon dioxide gases, metabolic waste, heat, and other nutrients with the cells [50]. For
patients suffering from coronary artery disease, the plaque in the vessel eventually builds up to a
point of occluding the lumen [9]. Another cause for ischemia arises when the artery is damaged
and is clogged from a thrombus that is formed [9]. In both cases, blood flow to parts of the heart
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muscle is ceased, causing the tissue to undergo hypoxia [51]. As the tissues suffocate, necrosis
ensues causing irreversible cell death [52]. This event is more commonly referred to as myocardial
infarction and can be visually referenced in Illustration 1.2. Unfortunately for the heart, its
fundamental contractile cellular units do not possess the ability to regenerate themselves [52]. As
a result, ischemia may cause patient death if reperfusion of blood to the heart’s tissue is not rapidly
achieved [51].
Individuals who survive a myocardial infarction successfully had reperfusion of
oxygenated blood to the myocardium in a timely manner [51]. Physicians accomplish reperfusion
through an angioplasty [51]. During this minimally invasive procedure, a catheter with a small
balloon is inserted into the patient’s vessels. Once at the point of occlusion, the doctor will inflate
the balloon until blood flow is re-established. Furthermore, the physician may insert a metal mesh
called a stent into the vessel to hold the artery walls open and prevent them from closing again
[51]. In cases where this is not possible, an alternative strategy to continue blood flow is to reroute
the blood around the occlusion. This is achieved through a coronary artery bypass graft (CABG)
[51]. For this procedure, nonessential blood vessels from other locations of the patient’s body,
commonly the great saphenous vein, is harvested and used as a guide to divert blood around the
narrowed vessel to the heart tissue. The three reperfusion methods may be visually referenced in
Illustration 3.2. Furthermore, treatment for a myocardial infarction can involve a pharmaceutical
cocktail of blood thinners, thrombolytics, anticoagulants, vasodilators, blood-pressure medication,
and pain relievers to prevent a future infarct event. In any manner, once blood flow is regained,
the heart muscle can begin to heal.
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Illustration 3.2: Current treatments for treating ischemic heart disease by reperfusing the
myocardium include an angioplasty procedure (A), a stent implant in the arterial
wall (B), and a CABG surgery (C). This figure was made using figures from
[53-55].
Hours after a MI, cardiac remodeling begins [13]. This is the heart’s method of repairing
itself after an injury. During this process, the heart gets inflamed [13]. Cellular debris is removed
from the mesh-like extracellular matrix by matrix metalloproteases that digest the mesh [13]. Once
apoptotic cells are freed, macrophages invade the heart to remove the fragments from the area to
make room for a placeholder material, since cardiomyocytes cannot proliferate into the area, as
mentioned before [13]. Vacant space at the sight of injury is then filled by fibroblasts by secreting
thick layers of collagen, creating a dense scar in the muscle wall as shown in Illustration 3.3. The
benefit of developing this scar is to restore some function back to the heart. However, over time,
the heart is stressed by the dead weight of the scar tissue as it must overcompensate for the noncontractability of the dense collagen layer [14]. The pumping efficiency of the heart is therefore
impeded over time. Since the body’s needs for blood will eventually be unmet by the heart’s ability
to supply it, the patient is at risk of additionally developing heart failure [14].
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Illustration 3.3: The presence of a healed fibrotic scar in the thick myocardium after an MI is
highlighted by the arrow in a transverse human heart section. This figure was
obtained from [56].
Recalling from Illustration 1.1, heart failure is another form of heart disease. Thus, the
occurrence of coronary artery disease (one type of heart disease), leads to myocardial infarction,
which can eventually lead to heart failure (another type of heart disease). This point further stresses
just how deadly heart disease can be, and how much of a biomedical need exists to produce
alternative solutions to these problems. To date, current solutions for heart failure aim to restore
the pumping efficiency of the heart. Strategies range from ventricular assistive devices to organ
transplants. Ventricular assistive devices are pieces of hardware that are installed to help the heart
pump blood throughout the body, thereby reducing the workload of the already stressed heart.
Organ transplants completely replace the heart with a donor heart which is almost analogous to
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replacing a poorly functioning car part with a similar one that works. Downfalls of these treatments
include the use of anticoagulants, hardware malfunctions, long waitlists for organ transplants, risk
of rejecting the organ along with the immunosuppressive cocktail prescribed to patients that can
cause opportunistic infections.
Cardiac tissue engineering using current state-of-the-art technology such as threedimensional bioprinting offers an alternative, potentially better solution for patients suffering from
myocardial infarction and heart disease as it overcomes some of the downfalls of current
treatments. For one, the engineered tissue can be patient-specific. Personalized medicine has been
increasingly popular as not everyone is the same and is better than medicine that generalizes by
demographic and risk factor. One way engineered cardiac constructs can be personalized is by
using the own’s cells, and therefore their own genetic material. Protocols currently exist in
harvesting dermal cells and inducing pluripotency by converting them into stem cells and then
differentiating these induced-pluripotent stem cells into cardiac cells. By obtaining the cells
autologously instead of allogenically, we can reduce the probability of immunorejection of the
tissues made in-vitro. Furthermore, the specificity of these tissues is amplified using 3D
bioprinting to pattern cell-laden scaffolds in such a way that mimics tissue architecture of the
patient. While the ultimate goal of tissue engineering is to produce whole organs on demand, the
ability to create smaller geometrically similar tissue patches still offers specificity and may be
advantageous as they can be quicker to produce. Engineered cardiac constructs are also
advantageous over installed hardware because the scaffolds on which the cells grow can be made
of materials that mimic the native extracellular matrix. Furthermore, these scaffolds are readily
vascularized by the host’s circulatory system.
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To date, as explained in Chapter 2, there are a handful of polymeric materials of both
synthetic and naturally-derived sources that have been used in tissue engineering. Hydrogels are
especially of interest due to their ability to hold large amounts of water within their polymer chains,
much like natural tissues. In addition to their compatibility with cells, these materials are
extrudable from a printing barrel, and maintain their shape once printed. As such, hydrogels must
be viscoelastic and crosslinkable for long-term stability of the bioprinted construct. Up to date,
bioprinted samples have been crosslinked in a variety of methods, including the use of ultraviolet
light and harsh chemicals [57]. Ultraviolet light is known to have negative effects on the
composition of DNA and is known to induce cancers and is even used for sterilization [58]. The
goal of this chapter, which revolves around Specific Aim 1A, is to develop a bioink composition
suitable for 3D bioprinting of two major cardiac cell types using visible light to crosslink the
bioprinted construct, along with fibrinogen, a naturally-derived polymer to overcome these current
shortcomings.
To accomplish this, a modified-gelatin named furfuryl-gelatin (gel-fu) was used and is
elaborated on in the next section. The extracellular matrix of the heart is primarily made of
collagen. One economical source of a similar material is gelatin, which has been widely used in
cardiac tissue engineering applications. In fact, gelatin is simply hydrolyzed collagen. It is
therefore logical to include this material in the development of a cardiac patch. Previously in the
lab, a colleague began to develop this material for use as a bioink for extrusion-based bioprinting.
In her study, Dr. Anil Kumar fabricated sheets of heterogenous cell types in a layered fashion using
3D bioprinting [34, 59]. Overall, cells within the construct remained viable and even showed tissue
formation by the coupling of the cells. The shortcoming of this study, however, came with the
material characterization of the scaffold. Rheological analysis found the elastic modulus of the
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crosslinked construct to be 1.7 kPa, a value well below the range of 9 kPa, the elasticity of the
native myocardium. The aberrant mechanical properties of the scaffold to that of native tissues
prompted the hypothesis that adding another biomaterial with the gel-fu base would afford a
structure that more mimicked native myocardium.
In this study, fibrinogen is added to gel-fu-based to create a second generation bioink. Its
feasibility as a scaffold for the culture of CM was assessed in square 3D-bioprinted constructs
laden with human AC16 CM and fibroblasts. The printed constructs were subjected to a dual-step
cross-linking process, first by subjecting them to visible light to facilitate the crosslinking of
furfuryl-gelatin, followed by the addition of a thrombin and CaCl2 solution to induce crosslinking
and conversion of fibrinogen to fibrin. Ability of this substrate to promote heterocellular coupling
between bioprinted human cardiac fibroblasts (CF) and CM was investigated toward the
applicability of this scaffold to mimic cardiac tissue.
3.3. MATERIALS AND METHODS
3.3.1. Bioink Composition
To engineer a 3D bioprinted cardiac patch, a bioink that is compatible with an extrusionbased bioprinter is needed. Building from a first generation bioink developed in the lab [59],
fibrinogen was added to the composition as it is a well-studied natural biopolymer that is known
to promote vascularization, points for cell adhesion, and is currently used in the medical field as a
surgical glue [60]. Keeping in mind one of the main goals in the development of a cardiac patch is
to eventually implant the 3D structure in-vivo, the properties that fibrin introduces to the scaffold
composition could be beneficial to accomplish this task. Furthermore, the ability of fibrinogen to
be crosslinked by its conversion into fibrin by thrombin introduces an additional advantage by
fostering the possibility of raising the structure’s stiffness to a higher value than previously
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achieved. Various concentrations of fibrinogen from 10 mg/mL to 60 mg/mL were tested against
the printability of the bioink, with a concentration of 60 mg/mL yielding the best results for
extrusion. This concentration has also been reported to best crosslink after bioprinting using 50
U/mL of thrombin in tandem with 80 mM CaCl2 solution [61]. We have therefore adopted the
same concentrations of fibrinogen, thrombin, and calcium chloride for this project.
In order to create 1 mL of the dual-crosslinked bioink described in this study, 155 mg of
furfuryl-gelatin was added to 990 µL of 60 mg/mL fibrinogen solution at ambient temperature.
Furfuryl-gelatin was synthesized and obtained from Dr. Ito’s laboratory at RIKEN in Japan [62].
Furthermore, fibrinogen solution was made and procured from Dr. Willerth’s lab at University of
Victoria in Canada [60]. The gel-fu and fibrinogen mixture was then heated in a water bath to 37oC
for one hour with intermittent stirring to facilitate the dissolving of the gel-fu into a viscous
product. In the dark, 10 µL of 5% stock Rose Bengal solution procured from Thermo Fisher
Scientific (Waltham, MA, USA) was added to the mixture to act as a photosensitizer as described
before [59]. For cell experiments, a cell suspension of 2x105 cells/mL was added to the bioink
composition before loading into a printing cartridge. A summary of the bioink composition used
in this study can be found below in Table 3.1.
Table 3.1. Components and their respective concentrations in 1 mL of bioink are listed.
Composition for 1 mL of Bioink
Component
Furfuryl-Gelatin
Fibrinogen (60 mg/mL)
Rose Bengal (5% w/v)
Cell Suspension

Amount
155 mg
990 µL
10 µL
~ 2x105 cells/mL
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3.3.2. Biofabrication
Once a homogenous bioink mixture is achieved, the bioink is ready for bioprinting.
Furfuryl-gelatin/fibrinogen bioink was loaded into a 10 mL plastic syringe (BD, Franklin Lakes,
NJ, USA) that acted as a printing cartridge during the biofabrication process. The mixture was
removed of any air bubbles by inverting the syringe and pushing the piston toward its outlet until
a small amount of bioink was extruded, removing any air in the process. A blunt 20 G stainless
steel printing tip (Huaha, Amazon, USA) with a 0.6 mm inner diameter was attached to the end of
the syringe and tightened with a luer lock to prevent it from being detached when pressure is
applied during extrusion. The syringe was then inserted into one of the printing barrels of the
BioBot 1 bioprinter (now the Allevi 2; Allevi, Philadelphia, PA, USA) and connected to the hose
of an external air pump. A photo of the bioprinter can be seen in Illustration 3.4.

Illustration 3.4: Cardiac tissue in this study was printed with the Biobot 1/Allevi 2 bioprinter.
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The barrel on the BioBot was warmed to 37oC, then using 18 kPa to 25.5 kPa of pressure,
bioink from the syringe was extruded through the printing nozzle in a thin filament which was
patterned at 3 mm/s into a square herringbone structure of dimensions 1 cm x 1 cm x 500 µm onto
a glass slide taped into a 100 mm x 15 mm plastic petri dish (Thermofisher) as further described
in section 3.4.1. Design and Structure. A summary of the printing parameters can be referenced
in Table 3.2.
Table 3.2. Bioprinting parameters for the construction of the cardiac patch are listed.
Bioprinting Parameters
Parameter
Nozzle Size
Printing Speed
Pressure
Temperature

Specification
20 G Stainless Steel
3 mm/s
18 kPa – 25.5 kPa
37oC

The geometry of the construct was designed with CAD modeling using Solidworks
(Concord, MA, USA) and uploaded to Allevi’s Repetier Host program, which was used to convert
the stereolithographic image into G-code. G-code are the set of instructions that contain the
specifics of how to print the structure that is read by the bioprinter. In order to retain the
architecture of the bioprinted structure, the scaffold was crosslinked in a two-step process. First,
the furfuryl-gelatin component of the construct was crosslinked with Rose Bengal and a visible
light lamp (Intelli-Ray 600, Uvitron International, West Springfield, MA, USA) for 2.5 min at 175
mW/cm2 intensity according to the manufacturer. The machine used to generate the visible light
can be referenced on Illustration 3.5 below. Rose Bengal has an absorbance of 500 –590 nm with
a maximum absorbance at 549 nm
oxygen molecules to generate singlet oxygen which, in turn reacts with furan derivatives
to afford crosslinking through the formation of furanendoperoxide” [62]. Mechanism of
crosslinking for the gel-fu is depicted in Illustration 3.6. Right after crosslinking with
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electromagnetic radiation, the structure underwent secondary crosslinking by exposing the
scaffold to 1 mL solution consisting of 900 µL of 80 mM Cacl2 and 100 µL of 50 U/mL thrombin
for 20 min to convert fibrinogen into a fibrin clot. A summary of the crosslinking procedure can
be referenced in Table 3.3.

Illustration 3.5: Visible light generated with an Intelli-Ray 600 was used in the first crosslinking
step of the bioprinted scaffold.
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Illustration 3.6: A schematic of the chemical crosslinking mechanism of gel-fu with visiblelight. This illustration was taken with permission from [62].
Table 3.3. Crosslinking components and their respective durations are listed.
Crosslinking of Bioink
Component
Visible Light (549 nm for RB)
Thrombin (50 U/mL)
Calcium Chloride (80 mM)

Amount
175 mW/cm2
100 µL
900 µL

Time
2.5 min
20 min

3.3.3. Biomaterial Characterization
Material properties of the acellular bioprinted scaffold were probed using scanning electron
microscopy, a swelling assay, rheology, and Fourier transform infrared spectroscopy. As this
project was one that was collaborative in nature, I do not go into detail about the specifics of the
protocols used to accomplish the material characterizations listed above; however, I include this
section and the pertinent observations in the results section for completeness. A full description
can be found in the published peer-reviewed article [47] or Dr. Anil Kumar’s dissertation [34].
3.3.4. Cellular Studies
3.3.4.1. iPSC & AC16 Cell Characterization, Cellular Viability
Human iPSC-derived cardiomyocytes and AC16 human cardiomyocytes were
tested for cell viability and appropriate cell markers such as cardiac Troponin-T. As this project
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was one that was collaborative in nature, I do not go into detail about the specifics of the protocols
used to accomplish the material characterizations listed above; however, I include this section and
the pertinent observations in the results section for completeness. A full description can be found
in the published peer-reviewed article [47] or Dr. Anil Kumar’s dissertation [34].
3.3.4.2. Cardiomyocyte Morphology Orientation, and Specificity
To visualize cardiac-specific markers and morphology, human CM AC16 cells were
immunostained with Myocardin (Myocd, Novus Biologicals, 1:200) antibody and coimmunostaining with a characteristic cardiac biomarker, troponin T (TrpT, Cell Signaling, 1:300)
at TTUHSC by Dr. Chattopadhyay.
Tracking of encapsulated cardiomyocytes within the bioink was achieved by prestaining
cells with PKH26 (Sigma), a general membrane dye that fluoresces red prior to their mixture within
the bioink. About 2 × 105 cells/mL were added and printed within casted 3D patterns and cultured
in an incubator (37 °C, 5% CO2). Qualitative assessment of cellular orientation was done after 24
h of culture without fixing the cells in the gel samples using a confocal fluorescence microscope
(Zeiss) to gather maximum intensity projection z-stack images.
3.3.4.3. Coupling of CM with FB
Human AC16 cardiomyocytes and adult human fibroblasts (Cell Applications Inc.) were
cultured and maintained in accordance with their vendor’s specific protocols. Early passages were
used for coupling studies. To observe coupling between heterogenous cell types, cells were prestained with florescent dyes, similar to cell tracking experiments laid out above. AC16
cardiomyocyte were labeled with red PKH26, while human fibroblasts were labeled with green
PKH67 (Sigma). Groups assessed included 2D wells, 3D bulk gels, and 3D bioprinted constructs.
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For all studies, the ratio of CM:FB was maintained with a 1:1 ratio, in accordance to published
literature. Total number of cells, however, was varied between two- and three-dimensional
cultures. Two-dimensional wells received a seeding density of 1 x 104 cells/mL, while 3D
experiments received 1 x 105 cells/mL. After pre-staining and mixing the appropriate ratio, CM
and FB were mixed into bioink, printed, and crosslinked. After 24 hours of culture, all cells were
fixed and stained with DAPI. Representative fluorescent images were acquired using a confocal
microscope at TTUHSC (Nikon). Acquired images were processed using ImageJ to assess the
preferential cell orientation along the printing direction in comparison with cells mixed in bulk.
Viable nonfixed cells were also used to confirm heterocellular coupling between CM and
CF. CM were prestained with PKH26, while CF with PKH67. A grid structure (5 mm x 5 mm)
using two similar, but separate bioink mixtures with 1 x 107 cells/mL were made using a 1:1
CM:FB ratio were bioprinted using a BioBot 1 (Allevi, USA). Controls included cells randomly
mixed in gels and crosslinked as these ratios are similar to those found inn native myocardium
[63].
Heterocellular coupling in cultured constructs were processed into 8−10 μm thick sections
and immunostained at TTUHSC. Samples were probed for Cx43 (1:500, Cell Signaling)
antibodies. This was followed by addition and incubation with either goat anti-rabbit IgG
secondary antibody/Alexa Fluor 594 or goat anti-mouse IgG secondary antibody/Alexa Fluor 488
conjugate, both of which are applied at a dilution of 1:1000. Samples were then washed 3x in 1X
PBS, mounted using Fluoromount-G with DAPI (Thermo Fisher Scientific), and imaged using a
confocal fluorescence microscope (Nikon). Acquired images were processed and analyzed using
NIS elements (Nikon) to obtain signal intensity for expression of Cx43. Quantified expression of
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Cx43 in CM bioprinted bulk-mixed samples were also stained for Cx43 and imaged as described
above.
3.3.5. Statistical Analysis
For each study, triplicate samples were created and analyzed. Numerical data is presented
as the mean ± standard deviation. In order to determine if the means of two independent samples
were significantly different, a t-test was applied to collected data. For the purposes of this study,
p-values less than 0.05 were considered statistically significant.
3.4. RESULTS AND DISCUSSION
3.4.1. Design and Structure
As explained before, 3D bioprinting affords geometrically similar architectures to native
tissues. To demonstrate this in the creation of the cardiac patch described in this study, a
herringbone pattern was adopted. A herringbone arrangement is one known to naturally occur in
native cardiac tissue, as motivated by the histological section in Figure 3.1A from the literature
[64]. Using this pattern as a source of inspiration for computer-aided design modeling, a thin
single-layered square cardiac patch of dimensions 1 cm x 1 cm x 500 µm was created, as can be
seen by the STL file in Figure 3.1B. The gross en-face morphology of an acellular 3D bioprinted
construct using the CAD model is displayed in Figure 3.1C.
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Figure 3.1: The design of the engineered cardiac patch for this study was inspired by the
geometry of native human cardiac tissue (A) and was constructed using CAD
modeling (B) before being 3D bioprinted (C). This figure was adopted with
permissions from [47, 64].
3.4.2. Material Characterization of Bioprinted Scaffold, Cell Viability
These results were taken from Dr. Anil Kumar’s dissertation and from the peer-reviewed
article introduced at the header of this chapter [34, 47]. I include the important results here for
complete description in the development of the cardiac patch. In brief, the important observations
included a difference in swelling from the first generation bioink, to the one developed in this
study. Because the scaffold in this study was crosslinked twice, it swelled to a lesser degree.
Furthermore, the average pore size in the gel-fu-fibrin scaffold was smaller on average as
compared to the first-generation scaffold. Rheological analysis revealed an average elastic
modulus of 9.76 kPa, which is in the range of native heart tissue. Furthermore, cells encapsulated
were found to have a 92% viability after 5 days of culture with significance (p<0.05) against the
dead cells within the scaffold.
3.4.3. AC16 CM Morphology, Specificity, and Orientation within Bioink
Elongated morphology, characteristic of cardiac myocytes, are observed within fibrin-gelfu scaffolds, as shown in Figure 3.2. Some AC16 cardiomyocytes show binucleation from DAPI
stains. Binucleation is also another feature characteristic of heart cells. Furthermore, Myocardin is
visibly expressed. Myocd is responsible for cardiomyocyte structure and sarcomeric organization
[65]. Reduced expression of this biomarker is associated with cell death [65]. Specificity of cardiac
phenotype was further confirmed by appearance of cardiac-specific Troponin-T.
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Figure 3.2: Immunoassayed AC16 CM against Myocardin, cardiac Troponin-T, and DAPI
markers reveal elongated morphology characteristic of cardiomyocytes. This figure
was taken with permission from [47].
PKH26-labeled AC16 cardiomyocytes for tracked after 24 hours of culture after being
bioprinted or cast in bulk hydrogel. Representative maximum intensity projection z-stack confocal
microscopic images for 3D-bioprinted and cast cardiomyocytes are displayed in Figure 3.3. Upon
inspection, it was observed CM within 3D-bioprined constructs oriented themselves along the
direction of bioprinted filaments in a herringbone pattern, similar to the CAD model shown
previously. On the other hand, cardiac cells within bulk gels showed no sense of organization in
comparison. Bioprinting therefore affords greater cellular organization fashioned in predetermined geometries that mimic native tissues. Although both 3D-bioprinted and bulk gels
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contained the same number of cells encapsulated within their structures, thickness of gels cannot
be controlled when crosslinking bulk hydrogel. Thus, visual detection of encapsulated cells in bulk
constructs was hindered as compared to bioprinted constructs where crosslinking was more
organized. Nonetheless, bioprinted cells expressed a higher degree of order than non-bioprinted
samples.

Figure 3.3: A comparison between cardiomyocytes in the developed bioink that are 3D printed
(A) versus manually cast in bulk hydrogel (B) reveal a sense of preferred
organization in bioprinted constructs after 24 hours of culture. This figure was
adopted with permission from [47].
3.4.4. CM-CF Orientation and Coupling
Coupling of cells is an important phenomenon that signals tissue formation. In the
myocardium, cardiomyocytes couple amongst themselves to form gap junctions with Connnexin43 (Cx-43), a cardiac-specific protein that regulates effective communication between cells. The
intercellular protein is also found between adjacent cardiomyocyte-fibroblast pairs. One function
of fibroblasts is to act as long-distance conductors that bridge gaps between cardiomyocytes with
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Connexin-43. Small degrees of expression of this protein therefore signal poor cellular
communication, tissue synchronicity, and tissue formation in the myocardium.
To study the dynamics of heterocellular coupling phenomenon between CF and CM with
the developed fibrin−gelatin-based bioink in-vitro, human CM and CF present in equal proportions
were seeded into tissue culture wells and in bioprinted constructs. Representative images of
coupling phenomena are displayed in Figure 3.4. Fixed 3D and 3D florescent images reveal the
coupling of heterogenous cell types within the bioink formulation. Nonfixed cells also displayed
coupling when printed in a cross-hatch fashion.
Preferential orientation was also assessed in bioprinted and bulk constructs of heterogenous
cell types. Cells that were 3D bioprinted revealed a higher long-range cellular organization A
comparison of plotted average intensity values representing nuclear cell density and cell
orientation, as characterized by the average intensity of detected nuclei of stained cells in
microscopic images as a function of pixel distance in Figure 3.4C. Average intensity values for
the bioprinted samples (black) exhibited more frequent peaks within the range depicted, indicating
a higher frequency of cells present in the preferred orientation compared to samples that were
nonbioprinted (gray).
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Figure 3.4: Coupling of cardiomyocytes and fibroblasts are confirmed within fibrin-gel-fu
scaffolds after 24 h culture in two-dimensional wells (A), and in 3D-bioprinnted
constructs (B, D). Heterogenous cells align themselves to a higher degree in
bioprinted samples (C). This figure was reproduced with permission from [47].
Cx-43 expression between human AC16 cardiomyocytes within 3D-bioprinted constructs
and bulk gels was investigated quantitatively (Figure 3.5). Cells within bioprinted samples, which
have already been established to have a preferred orientation and express coupling, were found to
express a higher degree of Cx-43. Guided by the pre-determined geometries afforded by
bioprinting, Cx-43 expression was stimulated when compared to cells that were mixed in bulk with
statistical significance of p=0.004. It is well known that the cell alignment and function of
cardiomyocytes are extremely important for the proper function of cardiac tissue and maintenance
of normal cardiac physiology. Our results strongly imply that adopting 3D printing clearly poses
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irreplaceable benefits on mimicking the native tissue structure and function, which is clearly
lacking in “bulk” controls.

Figure 3.5: Connexin-43 expression is seen to a higher degree in bioprinted constructs as
compared to controls of cells mixed in bulk. This figure was reproduced with
permission from [47]
3.5. CONCLUSION
Fibrinogen was added to furfuryl-gelatin to synthesize a bioink for three-dimensional
extrusion-based bioprinting to construct cardiac tissues in-vitro. Scaffolds bioprinted were dual
crosslinked using visible light to polymerize gelatin monomers and with thrombin and free calcium
ions to enzymatically convert fibrinogen into fibrin. Addition of fibrin into the bioink formulation
afforded constructs with favorable properties including porosity, swelling ability, and mechanical
properties that mimicked native heart tissue. Furthermore, cardiomyocytes embedded in bioprinted
samples showed preferential orientation that was guided by pre-determined architecture. Cellular
alignment in bioprinted constructs afforded better interconnection between cells as confirmed by
assessing Cx-43 expression. Furthermore, cardiomyocytes cultured within the hydrogel expressed
characteristic cardiac-specific markers such as Myocd and cTnT. Cardiomyogenesis was also seen
to occur between cardiomyocytes and fibroblasts in-vitro. We can conclude 3D bioprinting
afforded geometrically relevant tissues that physiologically displayed signs of native heart tissue.
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Engineering such tissues holds tremendous potential to translate these approaches into the clinical
setting to be used as grafts for necrotic and fibrotic myocardium and lays foundation toward the
ultimate goal of generating whole organs on-demand in-vitro. These constructs also hold promise
in disease modeling and development of pharmaceuticals. Limitations of this study was the
construction of thin tissues, as thicker tissues usually lead to necrosis due to lack of oxygen
transport. Future studies will focus on incorporating additional cardiac-resident cells for a
complete cell model. Furthermore, the construction of thicker constructs for clinical relevance will
also be explored.
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Chapter 4: The Cryo-Induced Myocardial Infarct Rat Model
Work presented in Chapter 4 was peer-reviewed and published in [66]. Therefore, a
majority of the images and information used in this chapter is based off the article cited above.
Permissions from publishers for figures and illustrations used in this chapter can be found in
Appendix A of this dissertation. Furthermore, the Institutional Review Board forms for the
experimental animal protocol (1086422-8) drafted by Dr. Binata Joddar and approved by UTEP’s
Institutional Animal Care and Use Committee can be found in Appendix B. Guidance, training,
and assistance with animals was done under the direction of the attending veterinarians Dr. Tamila
Stott Reynolds and Dr. Violeta Salais. This chapter fulfills the objectives set out in Specific Aim
1B.
4.1. ABSTRACT
One of the most commonly used methods to induce myocardial infarction in animal models
is by ligation of the left anterior descending coronary artery of the heart. Although this method
pathophysiologically mimics myocardial infarction, it is known to cause random nonreproducible
lesions, increase the probability of post-operative mortalities, and cause other cardiac events such
as arrythmias. Therefore, an alternative method to induce myocardial infarcts would be beneficial
to the scientific community. In this study, a myocardial lesion in Sprague-Dawley rats was
produced by performing a thoracotomy and making contact with the heart muscle using a cryoprobe cooled in liquid nitrogen. Tissue sections were harvested and stained using hematoxylin and
eosin to quantify muscle density, fiber length, and fiber curvature. These parameters were
compared with a control group of murine animals which underwent the same surgical procedure,
albeit were not subjected to cryo-infarction. Observations revealed reduced muscle density, cardiac
fiber length, and distorted fibers in infarcted tissue sections as well as signs of contraction band
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necrosis, typical of MI. This quantitative histological study of cryo-induced MI in a rat model
offers an alternative strategy to produce myocardial injury and can aid others inn studying cardiac
disease progression and in the construction of engineered cardiac tissues.

Illustration 4.1: Graphical abstract of the cryo-induced myocardial infarction murine model
developed in Chapter 4 of this dissertation. This figure was reproduced with
permission from [66].
4.2. INTRODUCTION
Cardiomyogenesis with oriented cellular orientation and cardiac-specific markers observed
in the 3D bioprinted cardiac patch in Chapter 3 showed the feasibility of engineering heart tissue
using additive manufacturing [47]. Furthermore, the bioprinted fibrin-gel-fu scaffold exhibited
favorable properties for tissue growth and recapitulated that mechanical attributes of native heart
tissue [34, 47]. In order to further examine the potential for 3D bioprinted constructs developed
in-vitro to be translated into the clinical setting, development of these tissues must first show
promise within a small animal model. Thus, the work presented in this chapter aims to adopt a
method of inducing a myocardial infarction within Sprague-Dawley rats, paving a way for in-vivo
study of 3D bioprinted constructs, such as the one developed in the previous chapter.
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As mentioned before, myocardial infarction occurs when the coronary arteries of the heart
are blocked from delivering blood to myocardium, thus killing the heart tissue [67].
Cardiomyocytes, and other resident cells, suffocate from the lack of oxygen transport, and
therefore begin to die [68]. This cellular debris left behind after an MI event is removed after
inflammation, and remodeling of the cardiac wall occurs through the deposition of a thick and stiff
collagen scar [69, 70]. Short-term, the scar restores some of the heart’s function, however over
time, the heart overworks itself as it must compensate for the stiff non-contractile properties of the
scar, eventually leading to heart failure [71]. In attempt to find a solution to this problem, numerous
research groups worldwide have attempted to engineer cardiac tissues in-vitro (Chapter 3) that
have the potential to be clinically translated to replaced necrotic and fibrotic myocardium [47].
One of the most common methods currently used to induce acute myocardial infarction in
animal models is through ligation of the left anterior descending (LAD) artery [72]. LAD is the
largest coronary in the heart that travels from the anterior interventricular sulcus to the apex of the
heart [72]. Pathophysiologically, LAD ligation most resembles the naturally-occurring heart
attack, making it an attractive option. However, many pitfalls exist with this method as well. It is
known to produce random, variable, and unpredictable areas of necrotic damage as shown in
Illustration 4.2 [73]. Additionally, due to this variability, a larger number of animal subjects are
needed to make any meaningful experimental inferences, and thus faces critiques by animal
protection efforts [74]. The procedure is also expensive, difficult to perform, especially in smaller
animals, and time consuming [74]. Furthermore, LAD ligation has been observed to increase the
occurrence of post-operative mortality resulting from the presence of cardiac arrhythmias,
bleeding, and pneumothorax [75]. Therefore, an alternative method to induce a lesion on the
cardiac wall in a more controlled manner can be beneficial to the scientific community.
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Illustration 4.2: LAD ligation of a mouse heart using a suture. This image was taken from [76].
An alternative technique to induce an acute MI-like lesion on the myocardial wall is
through cryo-infarction. Unlike LAD that mimics an actual ischemic myocardial infarction event,
cryo-injury is significantly different pathophysiologically. Yet, it results in a standardized lesion
that replicates patterns seen in ischemic MI such as coagulation necrosis, hemorrhage,
microvascular reperfusion, inflammation, and scarring [73]. Furthermore, the scarring from cryoinduced MI eventually leads to heart failure, making it an attractive alternative to study myocardial
injury [73]. Due to the innate variances in the naturally occurring MI, LAD ligation, and cryoinfarct myocardial wounds, there is exists a need to better understand and characterize the
underlying pathophysiology and disease progression of the cryo-infarction technique [70].
Understanding the development of a cryo-MI model will help researchers design better strategies
to engineer a cardiac patch and will give insights to the differences in disease progression from
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other models. The histopathological progress of a naturally-occurring MI is already well
documented and can even be used to understand the age of the infarct [77-79].
Cryo-infarction has also been successfully applied in other studies with very significant
outcomes [80], which prompted us to form the hypothesis that cryo-infarction can lead to an
optimized yet easily reproducible model of injury for the induction of MI in a rat model. Therefore,
it is essential to induce and optimize the cryo-MI procedure in rats which can eventually lead to
establishment of a model for induction of cardiac fibrosis and heart failure. In this study we adopt
histological quantification methods to characterize heart tissue subjected to cryo-infarction from
samples collected immediately after myocardial injury. This will provide a baseline in the study
of the pathophysiological progression of the lesion and help researchers in other endeavors such
as the design of engineered cardiac patches.
4.3. MATERIALS AND METHODS
4.3.1. Rat Model
Sprague Dawley (Hsd: SD) rats have been extensively used as an animal model to study
various facets of cardiology, including implantation and ventricular remodeling studies [81-83].
We have therefore adopted the use of these murine animals for this study since our goal is to
eventually implant 3D bioprinted cardiac grafts to test their efficacy. We also hoped to extend what
is known about cryo-infarction in the murine animals as literature has been limited to studies done
in mice [80, 84]. For this study, a minimum of n = 3 animals were used for each condition amongst
an approved total of 42 animals employed for the entire study. All animal experiments were
executed in accordance with the National Institutes of Health Guide for the Care and Use of
Laboratory Animals [85]. Procedures were additionally reviewed and approved by the Institutional
Animal Care and Use Committee at The University of Texas at El Paso. For this study, male and
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female Sprague Dawley (Hsd: SD) rats (Envigo, Houston, TX) of ~ 8–10 weeks at the time of
surgery were randomly separated into a sham group and an experimental group. The experimental
group underwent a thoracotomy, and myocardial injury was induced using a cryo-probe. The sham
group, on the other hand, underwent the same surgical procedures, however were not subjected to
cryo-injury. Although the use of animal models is slowly being replaced by tissue-on-a-chip
platforms, the need for an animal model is essential to develop the potential for the cardiac graft
presented in Chapter 3. To be more specific, the testing of biologics on small animal models is a
prerequisite required by the FDA in order to translate these products into clinical trials.
4.3.2. Chemicals
IsoSol (Isoflurane, USP), surgical-grade chlorhexidine solution, and ChlorHex-Q presurgical hand scrub was procured from Vedco Inc. in Saint Joseph, Missouri. The isolflurane was
used as an inhaled anesthetic, while the surgical solution and hand scrub were used to prepare the
site of operation on the animal. Lidocaine Hydrochloride Jelly USP, 2%, was purchased from
Akorn Inc. in Lake Forrest, Illinois and was used to numb pharyngal spasms during intubation of
the rat. Ethanol, Gibco 1X phosphate-buffered saline (PBS), Alfa Aesar 4% paraformaldehyde
(PFA) was bought from Fisher Scientific in Hampton, New Hampshire. The ethanol was also used
to sterilize the surgical site, while PBS and PFA were used to perfuse collected samples from
excess body fluids and preservation. Mayer’s Hematoxylin, Alcoholic Eosin, Sucrose, Xylene,
Bouin’s Fluid, Working Weigert’s Iron Hematoxylin Stain, Trichrome stain, Acetic acid, Sodium
Borohydrate were all acquired from Sigma Aldrich and were used to histologically process tissue
samples for analysis.
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4.3.3. Preoperative Procedures
A Sprague Dawley subject was weighed before each trial using a standard scale and was
input as a parameter for induction of anesthesia into a Somnosuite® Low-Flow Anesthesia System
(Kent Scientific Corporation, Torrington, CT). The Somnosuite was used to vaporize and
administer isoflurane loaded in a Pressure-Lok Precision Analytical Syringe (Valco Instruments
Company Inc., Houston, TX) in addition to regulating and monitoring the animal’s body
temperature, oxygen saturation, and pulse. The specimen was placed in an induction chamber
connected to the Somnosuite via clamped rubber tubing to control airflow. Before each trial, the
apparatus was calibrated and checked for any leakage of anesthesia. Once the animal was under,
it was removed from the chamber and placed supine onto a countertop a large nose cone (Kent
Scientific Corporation) was placed over the rat’s nose so isoflurane could continue to be
administered. Recovery from isoflurane occurs in a matter of seconds, thus the continuous
administration of anesthesia is imperative. The left thorax and axillary fur of the subject were
shaved and wiped clean with 70 % ethanol solution.
To prevent pneumothorax when opening the chest cavity, the rat had to be intubated. A Rat
Endotracheal Intubation Kit (Kent Scientific Corporation) was used to accomplish this task. After
shaving the fur at the surgical site, the subject was moved to an intubation stand and hung with
suture by its upper incisors under a nose cone. A pulse oximeter connected to the Somnosuite was
placed on the subject’s paw to monitor the oxygen saturation level, and a thermometer placed in
the rectum. Using a dental probe, the tongue was manipulated to expose the throat and lidocaine
was swabbed into the animal’s mouth to suppress laryngeal spasms during intubation. After
waiting a few seconds, A 16 G x 2” catheter (Nipro Medical Corporation, Osaka, Japan) was
inserted into the trachea, using a fiber-optic light for guidance. After a complete seal was made
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within the trachea, the fiber optic was pulled out, and the clamped rubber tubing was quickly
rearranged to ventilate anesthesia into the animal through the catheter. Once properly intubated,
the subject was moved to a sterile field on the top of a warming pad, and the surgical site was
wiped down with surgical scrub, ethanol, and surgical solution thrice. A schematic of the surgical
set-up can be referenced in Illustration 4.3 below.

Illustration 4.3: Surgical set-up to induce myocardial infarction in a rat model using a
cryoprobe. This figure was reproduced with permission from [66].

4.3.4. Cryo-Induced Myocardial Injury
A stainless-steel rod (316 SS, Arcelor Mittal), henceforth called cryo-probe, with 3 mm
cross-sectional diameter was placed into liquid nitrogen from the moment the animal was weighed
at the beginning of the protocol. Using a scalpel, a thoracotomy was performed through the fourth
left intercostal space [80]. The ribs were opened and held using an ALM self-retaining retractor
from a Rat Surgical Kit (Kent Scientific Corporation). After locating the heart, the thin pericardium
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was removed with the help of a stainless-steel blunt probe that was 14 cm long, 1.0 mm in diameter
and stainless-steel forceps. When the myocardium was exposed, the cryo-probe was removed from
the liquid nitrogen and cryo-infarction was induced by touching the tip of the cryo-probe to the
anterior left ventricular free wall for 10 s. Ice-cold PBS solution in a plastic syringe was then
perfused through the heart to remove any blood from the inner chambers. The animal was
sacrificed by removing the heart. Organ samples were fixed in 4% PFA overnight then switched
to PBS before tissue sectioning.
4.3.5. Tissue Processing
Tissue processing was done at TTUHSC after cryo-infarction procedures. To dehydrate
samples, heart samples were placed in 30 % sucrose and were bisected transversely from the apex
of the heart. Samples were embedded into Neg-50 tissue medium and sectioned using a cryo-stat
(ThermoFisher Scientific, Pittsburgh, PA) at 5 μm thickness (Roy et al., 2009). Tissue sections
were collected onto uncoated glass slides and stored at -80 ◦C. Sections were then transferred to 20 ◦C overnight before any dye staining procedures.
Cardiac tissue sections were stained with hematoxylin and eosin following a modified,
published protocol [86]. Slides were heated to 37◦C using a slide warmer (ThermoFisher
Scientific, Pittsburgh, PA) for 20-30 min then submerged in 4% PFA for the 10 min. To remove
tissue-embedding compounds, the sections were each rinsed twice in PBS, followed by a final
rinse in a gentile tap water stream. Tissue was stained with Mayer’s hematoxylin for 30 s, washed,
then was dipped in a series of diluted ethanol concentrations. Sections were counterstained with
alcoholic eosin, then were dehydrated through a second series of ethanol changes. Finally, tissue
sections underwent three changes of Xylene for a minute each, and a coverslip was mounted on
top of the section with xylene based mounting media. H&E-stained samples were imaged at 40x
magnification with a CoolSNAP MYO camera (Photometrics, Tucson, AZ) and imported to the
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computer for image-analysis and analyzed for cardiac muscle density, fiber length, and fiber
curvature as described below.
To estimate the presence of collagen, a modified protocol was used to stain for collagen.
This was done at TTUHSC in Dr. Chattopadhyay’s lab. In brief, samples were warmed and placed
in Bouin’s fluid at 56◦C for half an hour. Sections were then rinsed and subsequentially stained
with Working Weigert’s Iron Hematoxylin for 15 s and rinsed. Trichrome stain was applied for 15
min, moved to 1% acetic acid for 1 min, rinsed, and dehydrated in two changes of anhydrous
alcohol for 1 min each. Finally, tissue sections underwent three changes of Xylene for a minute
each, and coverslip was mounted on top of the section with xylene based mounting media. Samples
that were stained with Gomori’s Trichrome were imaged at 20x magnification with a CoolSNAP
MYO camera (Photometrics, Tucson, AZ) and imported to the computer for image-analysis and
analyzed for collagen, as described below.
4.3.6. Quantification of Muscle Density
Myocardial density in tissue sections was calculated using ImageJ (National Institutes of
Health, USA) through a color segmentation plug-in ColorSegmentation_.jar [87]. The eosinstained cytoplasm of cardiomyocytes was partitioned against the white background of histological
samples in RBG colored microscopic images. By splitting each color of interest in a channel, an
algorithm segments the two pigmentation clusters and calculates the area occupied by each. This
procedure was conducted on both sham and infarcted tissue sections, and an average area
percentage of fiber muscle was calculated for comparison. The area to be measured was objectively
random, and a total of twelve different sham and twelve different infarcted H&E micrographs were
used to calculate average muscle density from each animal.
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4.3.7. Quantification of Fiber Length
Cardiac fiber length was measured using ImageJ. The software was calibrated using the
scale bar displayed on the images of H&E-stained histological sections. A line was drawn n down
the center of a single fiber and the corresponding length was recorded. The average fiber length
was calculated for both the sham and infarcted groups for comparison by measuring a total of fifty
cardiomyocytes in each group.
4.3.8. Quantification of Fiber Curvature
Muscle fiber curvature was assessed for both sham and experimental groups. To do this,
two measurements per cardiac fiber were measured using ImageJ. A ratio of curvature (C) was
calculated by dividing the length along the contour of a cardiac fiber (Lc) to the length of the line
segment between its two end-points (Ls) as seen in the equation below.
𝐿!
𝐶=
𝐿"
Looking at the equation above, if Lc ~ Ls, then C~1 and the fiber displays a linear character.
On the other hand, C > 1, then the contour measurement is longer than that of a straight line,
thereby meaning the fiber is wavy. The ratio cannot be less than 1, as theoretically Lc can never
be less than Ls, since the shortest distance between two points is a straight line. After calibrating
with the scale bar, as done for fiber length measurements, ImageJ was used to measure Lc by
drawing small line segments along the curve of the cardiac fibers and summing them. Ls was
measured by drawing a line between the end-points of the same fiber. About fifty measurements
were used to calculate the average ratio of curvature for the cells from each group.
4.4. RESULTS AND DISCUSSION
4.4.1. Macroscopic Characteristics of Cryo-MI
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Figure 4.1: Inspection after cryo-infarction reveals a zone of reddish-brown tissue (A) which is
roughly the same dimensions as the cross-section of the 3 mm diameter stainless
steel probe (B). This figure was reproduced with permission from [66].
Macroscopic inspection of an excised rat heart after cryo-induced myocardial infarction
revealed a localized dark, brownish-red region roughly about the size of the 3 mm cryo-probe that
was used to produce the lesion as shown above in Figure 4.1. The discoloration seen agrees with
macroscopic findings in human coronary thrombosis-induced MI on relatively fresher infarcts as
opposed to older ones, which exhibit a more grey or white color [79]. The discoloration of the
localized region is indicative of tissue necrosis. A fresh infarct with a similar reddish-brown hue
is shown inn Illustration 4.4 for reference. Furthermore, the infarct has well defined borders that
resemble the stamp of where the injury was induced, which contrasts to the irregular infarcts seen
in LAD procedures, such as the one in Illustration 4.2.
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Illustration 4.4: A fresh, naturally-occurring myocardial infarct from a human is shown.
Discoloration highlighted by the arrows show necrotic tissue. This picture was
taken from [88].

4.4.2. Muscle Density
H&E-stained myocardial tissue sections representative of cryo-injured and control
specimens can be seen in Figure 4.2. Inspection of various sections for both groups revealed the
average area occupied by cardiac muscle to be 57 ± 4% for controls and 42 ± 6% for cryo-infarcted
tissue sections as can be seen in Figure 4.2C. Thus, muscle density is observed to be reduced after
induction of cryo-infarction with a statistical significance of p = 2.28 x 10-6.
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Figure 4.2 Representative H&E sectioned tissues for sham (A) and cryo-infarcted (B) samples.
Reduced muscle density (C), fiber length (D), and nonlinear fibers (E) are seen in
cryo-injured specimens as compared to controls. This figure was reproduced with
permission from [66].

A larger representative area for the sham and cryo-infarcted myocardium can be referenced
in Figure 4.3. Alteration in muscle density post cryo-MI is noticeable almost immediately in
comparison to the naturally occurring infarct where fiber density in the infarct sight is seen to
decrease days after onset of MI due to the digestion of cellular debris by inflammatory cells [13].
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Figure 4.3: Microscopic images (40x) over a larger area of sham (A) and cryo-infarcted (B)
tissue shows decreased muscle density on lesioned rats. This figure was reproduced
with permission from [66]
4.4.3. Fiber Length
Average length of cardiac muscle fiber was determined by measuring the longest
undisrupted span of each cell. Results are displayed in Figure 4.2D. Cardiac muscle fiber length
was found to be longer in sham tissue samples with an average length of 116 ± 25 μm as compared
to cryo-infarcted specimens whose average was calculated to be 68 ± 29 μm with a statistical
significance of p = 1.18 × 10−14. A survey of literature reports the average length of healthy cardiac
cells to be about 100 μm [13] which agrees with values seen from our control tissue sections.
Decrease in average fiber length in our study was introduced by the cryo-infarction procedure that
caused the shriveling of cells, thereby contributing smaller lengths in the experimental group’s
average. Nonetheless, introduction of cellular debris, either by apoptosis or cryo-infarction, is
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necessary to activate the heart’s innate healing response. This begins with inflammation that
removes these fragments and continues on to the remodeling of the cardiac wall characterized by
the deposition of a thick collagenous scar [13, 89]. Furthermore, a survey of literature finds a
direct contrast with findings found with LAD ligation experiments, where cardiac fibers in LADinfarcted rats appeared to be longer and caused hypertrophy of the cells [90]. This phenomenon
was not observed in our results.
4.4.4. Fiber Curvature
Cardiac fibers in sham tissue sections were observed to display a more linear geometry as
compared to cells that underwent cryo-infarction. This was confirmed by calculating a ratio of
curvature for both control and experimental groups. An average curvature ratio was calculated to
be 1.04 ± 0.03 for healthy muscle fibers. A ratio close to 1 indicates a more linear character. O the
other hand, cryo-infarcted fibers were found to have an average curvature ratio of 1.29 ± 0.23. The
aberrance from 1 indicates experimental groups contained fibers that deviated from a linear
character to a more distorted geometry. There was a significant difference of 3.15 x10−10 between
both groups, as graphically depicted in Figure 4.2E. Observation of wavy cardiac muscle fibers
after MI is a characteristic histopathologic feature commonly seen in the naturally-occurring MI
and in LAD ligation induced MI [78, 91]. Wavy fibers from a naturally-occurring MI is seen in
Illustration 4.5 below.
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Illustration 4.5: Wavy fibers at the sight of an infarct. This illustration was taken from [92]
4.4.5. Contraction Band Necrosis
Features of contraction band necrosis were also observed in our study as shown in Figure
4.4. Contraction band necrosis is known to occur within the first couple of minutes of a myocardial
infarction [93]. It as a type of uncontrolled cell death unique to cardiac myocytes and arise from
reperfusion from hypercontraction which results in the tear of the sarcolemma [93]. Characteristics
of this phenomena can be seen histologically by the disappearance of the contractile striations
naturally seen in cardiac muscle (Figure 4.4A). Furthermore, darker, irregular fibers that become
highly eosinophilic can be observed, as in Figure 4.4B. A tissue section from a naturally-occurring
MI is seen in Figure 4.4C for comparison with results from our study.
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Figure 4.4: Contraction band necrosis is observed in tissue sections of cryo-infarcted rats, but
not in control samples. Figures were was taken from [66, 94]
4.5. CONCLUSION
In this study, Sprague Dawley rats were randomly split into a control or experimental
group. The experimental group were subjected to cardiac cryo-injury, while the control (sham)
group were not. Hearts were harvested directly after procedure and were visualized using H&E
staining. Overall, histological sections taken from cryo-infarcted specimens displayed cardiac
muscle fibers that were not as spatially abundant, shorter, more distorted, and displayed signs of
contraction band necrosis compared to their sham counterparts. Furthermore, a localized area of
necrosis that resembled the stamp of the cryo-probe was seen upon macroscopic inspection. We
believe that this study is the first of its kind to perform extensive quantitative histopathological
analysis to confirm the observational outcomes, also reported earlier by many groups [77, 80, 84].
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These results imply that the cryo-infarction created in the rat animal model characterizes the
anterior myocardial infarct with modest adverse collagen-based extracellular matrix remodeling
and may be representative for infarcts seen in the clinic. Some of the limitations of this study
include the current inability to create transmural infarcts found in the middle layers of the
myocardium. Furthermore, as cryo-infarction does not pathophysiologically mimic the natural MI,
processes that arise due to ischemia itself, such as hypoxia and reperfusion, cannot be studied using
this method.
In future studies, we hope to use this data to better design and optimize a cardiac patch that
can be surgically grafted into a defined and specific zone of infarcted myocardium such as the one
developed in Chapter 3 [47]. We further aim to implement this technique at discrete timepoints
after cryo-injury to study the histopathological development of the induced infarct. While LAD
more closely resembles the pathophysiology of a naturally-occurring MI, the cryo-infarction
technique produces a defined area of infarction that researchers may find as a valuable alternative
in designing experimental protocols that minimize the variability in infarcted zones, and therefore
do not require as many experimental iterations. This also has the additional benefit of reducing the
number of animals used, and cryo-infarction is a relatively fast technique. Furthermore, this can
be studied without explicit heart failure (van den Bos et al., 2005). The animal model also
introduces the possibility of implementing transgenic subjects (van den Bos et al., 2005). We hope
to use the data from this study to better guide our design of a cardiac patch that can be surgically
grafted onto the infarcted myocardium.
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Chapter 5: Engineered Alginate-Gelatin Bioprinted Scaffold with Three Heterogenous
Cardiac Cell Types
Work presented in Chapter 5 has not yet been peer-reviewed and published. Permissions
from publishers for figures used in this chapter can be found in Appendix A of this dissertation.
This chapter fulfills the objectives set out in Specific Aim 2.
5.1. ABSTRACT
5.2. INTRODUCTION
Engineering cardiac tissues in-vitro requires recapitulating the complex tissue structures
seen in nature. As seen in Chapter 3, we can generate geometrically similar cardiac geometries
that enhance tissue formation using three-dimensional bioprinting. It was seen that two dominant
heterogenous cell types found in the heart, namely the cardiomyocyte and fibroblasts, begin to
couple when 3D cultured in-vitro. In this study, a third major cell type found in the heart, the
endothelial cell, is added to 3D bioprinted alginate-gelatin constructs. We hypothesize that the
addition of the third cell type will serve as a more complete in-vitro cardiac cell model. Endothelial
cells in the myocardium are generally found in the vasculature and serve to feed blood to the tissue.
They additionally release paracrine signals to the surrounding tissues that affect their growth and
behavior. They therefore could have an effect on the development of tissues, especially in cases of
remodeling of the myocardium.
Cardiac muscle adapts to changes in loading conditions [95]. For example, hypertrophy of
the left ventricle of the heart can be induced physiologically by exercise [95]. The same effect can
also be brought on pathologically as a consequence of hypertension [95]. Conversely, a decrease
in loading conditions of the heart causes the opposite effect and leads to cardiac atrophy. Cardiac
atrophy is characterized by the remodeling of the heart and that causes the decrease in the size and
69

mass of cardiac tissue due to cellular shrinkage from the loss of organelles, cytoplasm and proteins
[96]. It is well known cardiac atrophy afflicts patients with muscular disorders including
myopathies, such as muscular dystrophy, those suffering from cancer, and in people with diabetes,
sepsis, or heart failure. Furthermore, prolonged exposure to microgravitational conditions, such as
those experienced by astronauts, is also known to induce reduction in myocardial tissue mass and
weakening of cardiovascular health [95, 97]. As mentioned before, cardiomyocytes have little to
no regeneration potential. Thus, cardiac atrophy leads to further cardiac dysfunction and
maladaptive responses to disease or stress related conditions. Understanding the cellular and
molecular mechanisms involved in progression of cardiac atrophy can help early identification of
patients who are high risk or in the early stages of developing cardiac dysfunction. This
understanding will also provide new therapeutic targets for the prevention and treatment of cardiac
atrophy.
Although limited studies to study cardiac atrophy are underway, no well-established
cardiac tissue platform currently exists that can be used as a basis for such studies. Establishment
of a cell model system is of prime importance to study the resultant effects on cardiac tissues under
environmental conditions well-known to induce atrophy. For this reason, exposure to microgravity
during spaceflight may be an ideal environment for learning how it may lead to the development
of atrophy in cardiac tissue. We aim to develop a 3D cardiac organoid system with cardiomyocytes,
fibroblasts, and endothelial cells within bioprinted scaffolds to use as a foundation for studying
the effects of microgravity-induced cardiac atrophy. We hypothesize a 3D bioprinted cardiac
platform using three major cardiac cell types will serve as a more complete cell model that will be
extremely useful in probing atrophy in low gravitational conditions. Prior research studies have
shown the effects of microgravity on cardiac functions specifically highlighting the evidence of
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cardiac atrophy associated with long-duration exposures. As seen before, 3D culture allows cells
to self-organize by aggregation and facilitate spatially unrestricted interactions between cells and
their surroundings, circumventing the disadvantages of 2D culture that limit cell-cell signaling and
restrict cell growth in an artificial environment. Therefore, utilization of a combination of
microgravity and 3D culture will be extremely useful as a model system in this study. It may be of
added advantage to adopt 3D bioprinted models as the coupled cells will be entrapped within a
gel-like scaffold preventing their untimely dissociation from a normal adherent culture system,
under the effect of microgravity.
Eventual results from this study could reveal important insights to the underlying
mechanisms of atrophy of cardiac tissue and whose implications could be extrapolated to solve
compilations of the disease on earth. Thus, to get more accurate descriptions of what occurs during
pathological and physiological biological processes of the underlying mechanisms that lead to
cardiac atrophy, I am to characterize a 3D bioprinted cardiac tissue platform that promotes the
culture of three major heterogenous cell types of the heart that may be used to send on the
international space station for a period of time to serve as a cardiac tissue disease model platform.
5.3. MATERIALS & METHODS
5.3.1. Biofabrication
5.3.1.1. Preparation of Bioink
In order to create 2 mL of alginate-gelatin bioink, a stock solution of 10% w/v gelatin from
porcine skin (~300 g Bloom; Sigma-Aldrich, St. Louis, MO) was created in a beaker by mixing
the gelatin powder in Gibco 1X phosphate-buffered saline (PBS) with a magnetic stirrer. Mixture
was heated on a hot plate and continuously stirred until the gelatin powder was completely
dissolved and a clear solution was achieved. Gelatin provides RGD moieties that cells may use for
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cellular elongation, migration, and support as alginate is not bioactive. A volume of 1 mL gelatin
was pipetted from the beaker into a 5 mL conical tube. Into the same 5 mL conical tube, 1 mL of
combined cardiomyocyte-fibroblast-endothelial cell culture media was added. Finally, 0.14 g of
lyophilized Pronova UP MVG Sodium Alginate (NovaMatrix, Norway) powder was weighed and
added into the 5 mL tube so as to create a bioink with an alginate concentration of 7% (w/v) and
gelatin concentration of 5% (w/v). The combined components were vortexed, mechanically mixed
with a spatula, and centrifuged at 1200 rpm for 3 min to homogenize the mixture. This final step
was repeated until the 2 mL bioink was transparent and free from any clumped material.
5.3.1.2. Three-Dimensional Bioprinting
Freshly prepared 2 mL of alginate-gelatin bioink was transferred into a 3 mL plastic
printing cartridge with a piston (Cellink). A pink 20 G tapered conical nozzle (Cellink) was
attached and the cartridge was loaded into a pneumatic print head on a Cellink Bio X bioprinter.
Ring structures of 10 mm diameter and 1 mm height were printed into a 24-well plate at 80 kPa
pressure, 2 mm/s printing speed, and 30% infill with a concentric filling pattern. A summary of
printing parameters can be referenced on Table 5.1 and the bioprinter used for biofabrication is
seen on Illustration 5.1. After 3D ring structures were printed, they were crosslinked with 100
mM calcium chloride dihydride by pipetting 500 microliters of the ionic solution into the wells.
Ring structures were chosen with the hope of filling the inner-diameter of the ring with endothelial
cells to create the lumen of a vessel that is surrounded by cardiac tissue. The samples were allowed
to sit in the crosslinking solution for 5 minutes, after which the solution was removed.
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Table 5.1: Printing parameters for the scaffold developed in this study.
Bioprinting Parameters
Parameter
Nozzle Size
Printing Speed
Pressure
Temperature
Infill

Specification
20 G tapered
2 mm/s
80 kPa
27oC
30 %
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Illustration 5.1: Cellink’s Bio X extrusion-based bioprinter was used for biofabrication of
circular constructs in this study.
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5.3.2. Material Characterization of Alginate-Gelatin Hydrogel Scaffold
5.3.2.1. Stability of Structures
Crosslinked 3D bioprinted structures were subjected to swelling in 1 mL of combined
CM:FB:EC media for 3, 10, and 21 days in experimental conditions (i.e. within an incubator). The
samples were imaged using a Leica microscope (Illustration 5.2) at each respective timepoint to
look for any macroscopic physical degradation of the 3D structure.

Illustration 5.2: Leica microscope was used for low magnification analysis of scaffold
degradation in this study.
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5.3.2.2. Swelling Analysis
Experimental protocol on the international space station requires bioprinted samples to be
viable in space-flight up to 21 days. Therefore, the swelling behavior was monitored for 21 days
in culture conditions (37oC, 5% CO2). Additionally, media was changed every 4 days. For
swelling, n=4 ring structures were printed and crosslinked using procedures mentioned above.
After crosslinking, structures were left at -80oC overnight, then lyophilized. The dry weights (W0)
of the lyophilized structures were recorded. The samples were then submerged in 1 mL of DMEM.
Every 24-hour period, each structure was wiped of excess moisture using a Kimwipe. Their
swollen weights (Wt) were then measured. After all weights were recorded, a swelling ratio for
each timepoint was calculated using:

𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑅𝑎𝑡𝑖𝑜 =

𝑊# − 𝑊$
𝑊$

5.3.2.3. Scanning Electron Microscopy
Average pore diameter of the acellular alginate-gelatin bioprinted scaffolds were recorded
at 3, 10, and 21 days in culture conditions by analyzing electron micrographs of cross-sectioned
lyophilized samples [47]. Bioprinted ring structures were allowed to swell up to 3, 10, and 21 days
after which they were removed from media and put in -80oC freezer overnight. Samples for each
timepoint were lyophilized and sputter-coated with gold/palladium (2–3 min) in a sputter coater
(Gatan Model 682 Precision etching coating system, Pleasantown, CA, USA) and visualized using
SEM (S-4800, Hitachi, Japan) at 7 kV voltage and current of 5 µA at varying magnifications.
Collected images obtained were analyzed using Image J to determine the average pore diameter of
during each timepoint as done before [47]. A total of n=25 pores were measured for each timepoint.
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5.3.2.4. Rheology
In order to assess the bioink composition, rheometric analysis of the material was
conducted on an MCR 92 Anton Paar rheometer with a 25 mm parallel plate geometry and a 1 mm
gap between the geometry and the stage. Studies on the bioink composition were conducted at
ambient temperature as the hydrogel is to be bioprinted at room temperature. The viscosity of noncrosslinked bioink samples were tested in a continuous flow experiment. Alginate-gelatin bioink
was assessed through a ramp of the shear rate from 0.1-100 Hz to determine if the material
exhibited shear-thinning properties. Shear-thinning is a crucial parameter needed for extrusionbased bioprinting. In addition, the bioink composition was analyzed before and after the addition
of calcium chloride to rheometrically measure crosslinking of the hydrogel.
To determine the limit of the material’s linear viscoelastic range and yield stress, small
amplitude oscillatory shear was applied to the samples in an amplitude sweep that with a strain
from 0.1%-150% at a constant frequency of 1 Hz. From this evaluation, an optimal strain within
the linear viscoelastic region was chosen to keep as a constant during a frequency sweep from 1000.1 rad/s.
In addition to evaluating the bioink composition, the mechanical properties of the
crosslinked scaffold were evaluated 3, 10, and 21 days after swelling in PBS. Alginate-gelatin
scaffolds were bioprinted in circular discs at 25 mm diameter and 1 mm height. These structures
were crosslinked as mentioned above, and allowed to swell in a 6-well plate in PBS. At each
respective timepoint, a total of n=5 samples were evaluated with amplitude and frequency sweeps
as mentioned in the previous paragraph. Storage and loss moduli were assessed for samples from
each timepoint.
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5.3.2.5. Fourier Transform Infrared Spectroscopy – Attenuated Total Reflectance
Chemical compositions of the scaffolds were monitored by taking absorption infrared
spectra. Alginate-gelatin bioink and printed into circular geometries and crosslinked as mentioned
before. Acellular scaffolds were allowed to swell in Gibco 1X phosphate-buffered saline. PBS was
changed every 4 days as usual, and the structures were kept in standard culture conditions (37oC,
5% CO2). After day 3 and day 21 of swelling, samples were dried of excess fluid using a Kimwipe.
Samples from each of the two timepoints were measured using ATR-FTIR machine
(ThermoFisher) with a diamond crystal accessory. An average of 32 scans per sample were taken
over 400 cm-1 to 4000 cm-1 for each of the two timepoints. Background from diamond accessory
was subtracted before each reading.
5.3.3. Cellular Studies
For studies that involved cells, sterile-filtered reagents, autoclaved equipment, and aseptic
protocols were used to minimize contamination of the gel. Human AC16 cardiomyocytes, adult
human fibroblasts (Cell Applications Inc.), and human dermal microvascular endothelial cells
(Sigma Aldrich) were grown, stabilized, and pre-stained with PKH26, PKH67, and CellTracker
Violet respectively. Cells were then counted and combined into a cell pellet of about 2x106 total
cells in a 2:2:1 ratio (800,000 CM: 800,000 FB: 400,000 EC). The ratio of cells was chosen in line
with help from numbers reported in literature [63] as well as to remain consistent with our previous
studies [47]. Furthermore, the number of endothelial cells included was chosen in accordance with
a pilot 2D optimization study conducted by Dr. Chattopadhyay’s lab at TTUHSC El Paso. The cell
pellet was resuspended in 90 microliters of combined culture media then pipetted into the 5 mL
conical tube containing 2 mL of bioink. The cells were mechanically mixed within the hydrogel
with a sterile spatula to disperse the cells before loading the cell-laden bioink into a 3 mL printing
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cartridge. After bioprinting, cells were maintained in 1 mL of combined media in each well of a
24-well plate. The media was changed every 4 days to mimic experimental conditions on the ISS.
A total of n=5 structures were evaluated at timepoints 3, 10, and 21 days. Constructs were
immersed in 4% paraformaldehyde solution to fix cells prior to confocal fluorescent imaging on a
Zeiss microscope.
5.3.4. Statistical Analysis
All experiments were performed inn triplicates, unless otherwise stated. Data in this study
is presented as the mean ± standard deviation. In order to determine if the means of three
independent datasets were statistically significant, a one-way ANOVA with a post-hoc Tukey’s
multiple comparison test was used for evaluation. P-values where p < 0.05 were considered
statistically significant.
5.4. RESULTS AND DISCUSSION
5.4.1. Biofabrication
A circular structure of 10 mm diameter and 1 mm height were bioprinted with MVG
alginate-gelatin bioink as shown in Figure 5.1. These structures were able to directly be printed
within a 24-well plate and crosslinked. The resultant structure appears to be transparent and rigid
enough to hold up with forceps without losing its geometry. For spaceflight, circular bioprinted
constructs will be put into 24-well inserts.
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Figure 5.1: Bioprinted ring structures directly after the crosslinking procedure is shown to be
transparent and rigid enough to be picked up with forceps. Structures are to fit in
24-well plate inserts.
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5.4.2. Structure Stability, Transparency, and Average Pore Size
Evaluation of the alginate-gelatin scaffold revealed a stable structure that withstood three
weeks of culture as shown in Figure 5.2. The bioprinted scaffold was transparent throughout the
three-week period as seen in the first row of the figure. Ability to see within the scaffold is
imperative as cells that will be embedded will be live-imaged and monitored from the ISS using a
microscope. Furthermore, the integrity of the scaffold was qualitatively examined through its
macroscopic features. Ring structures were seen to maintain their bioprinted geometries
throughout 21 days with high fidelity. Although the structures were relatively stable throughout
this timeframe, minor signs of segregation were seen within the structures, characterized by small
cracks within the scaffold as culture time progressed as seen in the second row in Figure 5.2.
Microstructure of the scaffolds were evaluated using SEM images at 3, 10, and 21 days where
average pore diameter was assessed. Alginate-gelatin scaffolds had an average pore diameter of
117 ± 41 μm after 3 days, 210 ± 110 μm after 10 days, and 126 ± 57 μm after 21 days of culture,
respectively. In comparing with swelling data, the average pore diameter was seen to increase as
hydrogel swelling increased. There was a statistical significance (p<0.05) in pore diameter at 10
days of scaffold culture. This significance was seen to occur when the hydrogel was at its
maximum swelling (equilibrium swelling). Furthermore, the average pore diameter was measured
to be slightly larger between timepoints 3 and 21, possibly due to the slight degradation of the
scaffold. However, this difference posed no statistical significance. Overall, the scaffold was seen
to be stable, with few indications of degradation. Scaffolds will be further evaluated in a
microgravity-simulating bioreactor to further evaluate the applicability of the three-dimensional
scaffold to withstand spaceflight conditions.

81

Figure 5.2: Integrity of the scaffold over 3 weeks of culture show minimal signs of degradation.
Furthermore, the scaffold remains transparent throughout the 21-day period,
making it accessible to imaging. The average pore size within the scaffold increases
as the structure swells.
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5.4.3. Swelling of Three-Dimensional Construct
Acellular bioprinted alginate-gelatin bioprinted constructs were asses for hydration
behavior over a 21-day period in DMEM as depicted in Figure 5.3. Representative photos of an
unswollen, lyophilized sample and one swelled to equilibrium are shown. The structure is observed
to be smaller than the diameter of a penny and swells a little above a penny’s thickness. Over a 21day span, the hydrogel gradually swells until it reaches equilibrium swelling at around 6 days in
media. It remains maximally swollen for about a 10-day period. Degradation of the scaffold from
swelling data is seen to occur after being in media for 16 days.
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Figure 5.3: Alginate-gelatin scaffolds were bioprinted and subjected to swelling for 21 days. (A)
shows the scaffold with no swelling on the left column and at equilibrium swelling
on the right. The degree of hydration for the scaffolds was monitored for 21 days
(B).
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5.4.4. Rheological Assessment
5.4.4.1. Bioink Characteristics
Shear-thinning character of the bioink composition was observed when examining the
continuous flowability of the material. Figure 5.4 graphically illustrates a representative sample
that observes shear-thinning behavior as the hydrogel’s viscosity is seen to decrease with
increasing shear rate [98]. Shear-thinning is an important phenomenon that directly relates to the
printing fidelity of extrusion-based bioinks [98, 99]. It describes the ability of a material to be
extruded from the ink cartridge during the bioprinting process. As pressure increases in the printing
nozzle, the viscosity of the hydrogel decreases, facilitating the deposition of a cylindrical filament
[35, 98, 100]. After this pressure is removed, such as when the hydrogel exits the printing nozzle’s
orifice, the viscosity of the material quickly increases causing the material to hold its deposited 3D
shape [35, 98-100]. Shear-thinning properties of hydrogels also serve to reduce the shear stress on
the encapsulated cells in three-dimensional bioprinting, thereby increasing cell viability during the
fabrication process [98, 101]. From this point of view, the data suggests the consistency of the
alginate-gelatin mixture would make for an ideal extrusion-based bioink.
The linear viscoelastic region (LVR) and yield stress of the bioink composition was found
by conducting small amplitude oscillatory shear (SAOS) on samples. Amplitude sweeps at a
constant frequency of 1 Hz for stress amplitudes that produced strains from 0.1-500% were
evaluated for n=6 samples. A representative stress sweep graph showed a constant linear plateau
region of the storage modulus (G’), appropriately named the LVR. In this region, the material is
structurally stable [102]. At higher shear stress, the material undergoes irreversible structural
change, and the linear plateau decreases rapidly. Therefore, any strain value within the LVR is
safe to use for other SAOS tests. Frequency sweeps, for example, can reveal information about gel
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structure and mechanical behavior by sweeping at a constant strain percentage within the LVR
[35, 102]. The associated strain curve was used to choose a strain of 10% to conduct frequency
sweeps on the bioink composition as it was within the LVR calculated by Anton Paar’s software
against the Herschel-Bulkley Model.
Further analyzing amplitude sweep graphs of the bioink, it can be observed the solid
behavior of the bioink predominates for low stresses as G’>G”, up until an intersection point of
the storage and loss moduli. The point where the storage and loss modulus intersect is the yield
stress, or the stress required to make a fluid flow [99]. After this point, G”>G’ and the viscous
nature of the bioink predominates. Materials with no yield stress (i.e. water) behave like natural
fluids and begin to flow with little to no applied stress [99]. We are also able to characterize the
bioink consistency on a scale from fluid, paste, and putty, based on the yield stress [99]. Materials
with a low yield stress easily flow, while higher yield stresses are attributed to materials that are
easily molded [99]. Pastes have a yield stress from 100 Pa – 2,000 Pa while putties observe a yield
stress greater than 2,000 Pa [99]. The average yield stress of the bioink composition for n=6
samples was calculated to be 1438 ± 497.3 Pa, thereby classifying the material composition within
the paste regime and suggesting the flow of the material at this stress.
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Figure 5.4:. Shear-thinning properties of the composite bioink are graphically represented.
Viscosity of the hydrogel is seen to decrease with increasing shear rate, thus making
the material composition a good bioink candidate for extrusion bioprinting. Axes on
the graph are in logarithmic scale.

5.4.4.2. Temporal Mechanical Properties of 3D-printed Scaffold
From the amplitude sweep, a 10% strain was chosen as a constant to conduct SAOS
frequency sweeps of the material from an angular frequency of 0.1-100 rads/s as seen in Figure
5.5. By examining the frequency dependance of the storage and loss moduli, we are able to deduce
important aspects of gel character and mechanical behavior such as degree of crosslinking,
entanglement, glass transition, and details about chain architecture [103]. The data in Figure 5.5
suggests the bioink is unstable the elastic and viscous properties of the material are variable at a
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constant strain within the LVR. At lower frequencies, the material behaves as a viscous liquid
becomes more elastic with increasing frequencies due to the decrease in relaxation time of the
material’s molecules thereby favoring the storage modulus [101]. If the material were to be stable,
such as when it is crosslinked, the appearance of a plateau within the frequency sweep appears,
which in turn, allows for relative comparison of the stiffness of the material. This uncrosslinked
bioink data with be used as a negative control to confirm the crosslinking of the hydrogel shown
as Day 0 data in Figure 5.5.
Further analysis of the solid-like properties of the scaffold were examined and are
presented in Figure 5.5 (right). As mentioned before, Day 0 on the graph represents the
crosslinked bioink, right after crosslinking with calcium ions for 5 minutes. As compared to the
graph on the left, we see that the structure becomes stable after crosslinking. Swelling of the
scaffold significantly (p<0.05) decreases the solid-like properties of the scaffold. The constructs
are still seen to be stable, characterized by the plateau in the storage modulus for each timepoint
the crosslinked scaffold was analyzed. There was no significant difference in the mechanical
properties of the scaffold at days 3, 10, and 21. However, the average storage modulus was seen
to increase on day 10. This could be caused by the equilibrium swelling of the scaffold. Much like
a water balloon filled to its maximum, the scaffold’s elastic effects increase, and decrease again
when the swelling ratio goes down. Overall, rheological analysis shows stability of the threedimensional construct over a 21 day culture period.
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Figure 5.5: Rheological characterization of alginate-gelatin bioink and scaffold shows an
unstable bioink composition (left) that gets stabilized into a rigid structure when
crosslinked (right). The solid-behavior of these bioprinted scaffolds decreases as the
scaffolds swell with media.

5.4.5. Chemical Composition
Chemical composition of bioprinted acellular scaffolds were examined after 3 and 21 days
of swelling within PBS using ATR-FTIR spectroscopy. Spectra from Day 3 was gathered and
subtracted from Day 21 spectra to give a spectrum of the difference in vibrational peaks between
both timepoints as shown in Figure 5.6. A representative difference spectrum is also displayed in
Figure 5.B with a magnification inset in an area of importance. Bands of interest appear which
reveal information about the degree of crosslinking and stability within the calcium-crosslinked
hydrogels from Day 3 to 21. Peaks of interest include bands at 1588 cm-1, 1415 cm-1, 1078 cm-1,
and 1021 cm-1. The first two peaks mentioned are associated with the symmetric and asymmetric
stretching of -COO- of carboxylic acids and are specific to ionic bonding [104].
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The shoulder at 1078 cm-1 relates to the C-C and C-O stretching [104]. In literature, this
band is seen to strengthen when sodium alginate is crosslinked with calcium ions, and the ratio of
gelatin in an alginate-gelatin scaffold decreases [104]. We can therefore also infer that the content
of gelatin within the scaffold reduced from 3 to 21 days of swelling and/or the crosslinking density
of sodium alginate is reduced. This data seems to make sense with swelling data where alginate is
seen to degrade after 15 days of swelling as the swelling ratio falls from equilibrium. According
to band 1078 cm-1 in FTIR data, this could be because the relative concentration of gelatin could
be dissolving from the scaffold, especially since it was not crosslinked [104].
Moreover, a greater peak around 1021 cm-1 significant of C-C stretching is known to be
due to stronger binding of calcium ions to alginate [104]. According to our data, the peak around
1021 cm-1 is seen to be at a higher intensity after 3 days of culture versus 21 days. The decrease in
intensity of this band from day 3 to day 21 of swelling could mean that the alginate structure is
showing additional signs of degradation by the loosening some of its crosslinks by termination of
culture. Alginate disintegration occurs in the “egg-box” structure created by guluronic acid
residues as calcium ions are released [105]. Electrostatic repulsion between carboxylate anions
enhances alginate swelling and eventually facilitates their erosion into soluble alginate molecules
[105]. Thus, we can conclude that alginate-gelatin scaffolds in this study chemically show signs
of degradation through the dissolving of gelatin from the scaffold, as well as by the degradation of
crosslinks present in the alginate backbone of the hydrogel. The amount of degradation of the
scaffold was not seen to significantly affect the mechanical properties of the constructs as seen
from rheological assessment.
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Figure 5.6: FTIR spectra of crosslinked alginate-gelatin spectra after 3 and 21 days of swelling.
A difference between the two spectra reveals minor degradation of the alginate
crosslinks and dissolving of the gelatin from the structure.

5.4.6. Cellular Studies
Fluorescent confocal images of cardiomyocytes, fibroblasts, and endothelial cells within
3D bioprinted ring structures are shown at 3, 10, and 21 days in Figures 5.7-5.9 respectively.
Three different areas per sample were analyzed. At 3 days of culture, not many cells can be seen,
especially endothelial cells. This is probably due to a low cell seeding density into the bioink prior
to printing. Another observation that can be made at this timepoint is the coupling of
cardiomyocytes and fibroblasts, as indicated by the circled example in Figure 5.7. The same
circled object also shows that there is elongation in the morphology of some cells, however most
of the cells in the confocal images at this timepoint appear rounded in character. At 10 days in
culture, a greater number of cells can be seen. Coupling of CM and FB is still observed in greater
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number. Two other types of coupling can be seen in the representative confocal image in Figure
5.8. Spatial interaction between ECs and FBs is highlighted with a square border. Further, a
complete interaction between all cell types can be seen at this timepoint, as indicated by the arrows.
Finally, at 21 days of culturing the bioprinted constructs (Figure 5.9), most of the three cell types
appear to be coupled together. The most common coupling seen here is the unison of CM-FB-EC,
followed by EC-FB and CM-FB coupling. The morphology of the cells still appears rounded
within the gels. A graphical representation of cell couplings per unit area are graphed for Days 3,
10, and 21 respectively. There was a significant difference (p=0.01) in the amount of total cell
couplings at Day 3. I define “total couplings” to by any colocalization of any 2 of 3 heterogenous
cell types. The low total number of couplings at the beginning could be due to a low seeding
density to where cells were low in number and were so dilute within the scaffolds to a point where
they have not migrated to find neighboring cells. As cells were allowed to proliferate and migrate
within the scaffold, by the end of the culture period, a significant number of couplings occur where
all three cell-types are present, thus signaling cardiomyogenesis.
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Figure 5.7. Confocal fluorescent microscopic images of the three heterocellular cell types on the
3rd day of culture. Cells, specifically CM and FB begin coupling.
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Figure 5.8. Confocal fluorescent microscopic images of the three heterocellular cell types on the
10th day of culture First signs of all three cell types coupling occurs at this
timepoint.
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Figure 5.9. Confocal fluorescent microscopic images of the three heterocellular cell types on the
21st day of culture The total number of couplings where all three cell-types are
involved is significantly higher at this time.
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Figure 5.10: Number of couplings per unit area of the three cell types are seen to increase over
time with a significant difference at day 3 timepoint (blue). Coupling of all three
cell types together is also seen to increase over time with a significant difference at
day 21 (maroon).

96

Chapter 6: Effect of Varying Scaffold Mechanical Properties on Cardiomyocytes: A
Cardiac Fibrosis Model and Guide for Bioink Selection
Work presented in Chapter 6 was peer-reviewed and published in [37]. Therefore, a
majority of the images and information used in this chapter is based off the article cited above.
Permissions from publishers for figures and illustrations used in this chapter can be found in
Appendix A of this dissertation.
6.1. ABSTRACT
Hydrogels have been widely used in biomedical engineering as they are biocompatible,
resemble the three-dimensional extracellular matrix (ECM) of native tissues in the body, and their
stiffnesses can be easily tunable by changing their degree of crosslinking. In this study, alginate
was used as a 3D scaffold to culture cardiomyocytes within different mechanical environments to
understand the role ECM stiffness has in the alteration of cellular function. Three different gel
stiffnesses that mimicked various developmental stages of the heart, namely embryonic,
physiologic, and fibrotic states, were fabricated by varying the degree of crosslinking.
Characterization of the scaffolds revealed an inverse relationship with average pore diameter and
substrate stiffness. Hydrogel swelling followed the same trend. Cardiomyocytes cultured within
softer hydrogels demonstrated enhanced cell spreading, elongation, and network formation.
Increase in gel stiffness diminished these behaviors. Cell viability decreased with increasing
hydrogel stiffness. Furthermore, cells in fibrotic gels showed enhanced protein expression of
Troponin-I, a well-known biomarker for cardiac stress, and a diminished expression of the cardiac
gap junction protein, Connexin-43, as compared to cells within softer gels. Results from this study
demonstrate the importance mechanical properties have on tissue formation and its implications
in patients who suffer from fibrosis. Furthermore, results from this study also show the importance
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of material mechanical properties when choosing hydrogels to use as bioinks for three-dimensional
cell culture.
6.2. INTRODUCTION
We have seen in previous chapters of this dissertation, the utilization of hydrogels as
bioinks to construct three-dimensional cardiac tissues using extrusion bioprinting [47]. These
biomaterials are biocompatible, swell to hold large amounts of water within their porous and
networked architecture that permit the distribution of nutrients, mimic the extracellular
environment of native tissues, and provide a scaffold that guide cellular migration and growth
[106]. They have been used for a wide array of biomedical applications including defect restoration
[107], wound healing [108, 109], drug delivery [110], stem cell differentiation [106], and
biosensors [111]. They have been used to fashion a breadth of tissue types such as skin, heart,
bone, and others [5, 21, 47, 112, 113].
Hydrogels also have the ability to be crosslinked through physical or chemical means, as
seen in Chapter 3 and Chapter 5 [21, 47, 59, 114]. Once crosslinked, bioprinted structures are able
to retain their structural fidelity, even in aqueous environments, and provide mechanical support
for developing tissue [115]. It is well known that the more crosslinked a hydrogel is, the stiffer it
becomes [116]. In this study, I aim to exploit the ability to modulate biomaterial stiffness that
arises from crosslinking to mimic the extracellular environments of three developmental stages of
the heart: embryonic, physiologic, and fibrotic. During these three distinct heart phases, the
extracellular matrix has different mechanical properties.
Stiffness of tissues is a dynamic property that plays a direct role in normal physiology,
development, and diseased states [117, 118]. Extracellular matrix (ECM) is a dynamic
environment that constantly undergoes remodeling during various biological processes. Due to
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these changes in mechanical properties of the microenvironment where cells are embedded, the
physiology of the cells changes accordingly. In the human heart, the elastic modulus of the
myocardium which develops from an embryonic value in the low kPa regime (2–4 kPa) [119]
significantly increases to a value around 9 kPa as the heart matures to its physiologic value [119].
Aging, or fibrosis from hypertrophy or myocardial infarction further increase the stiffness of the
heart [120]. Biophysical characterization of the extracellular environment of cardiomyocytes thus
far in two-dimensional culture has shown that extracellular stiffness plays an important role in
cardiomyocyte physiology. Stiffness has been seen to cause adverse disruption of calcium
transients, force generation, and alignment of sarcomeres during maturation [121]. Mechanotransduction pathways of cellular response to mechanical environments have been increasingly of
interest, especially in tissue engineering applications. The overall objective of the present study is
to develop a hydrogel system to model cardiac myocyte behavior in progressively stiffer substrates
representing healthy (embryonic and physiologic) and diseased (fibrotic) cardiac tissue to study
the underlying mechanisms involved in modulation of cardiomyocyte behavior and function.
Alginates have demonstrated extensive applicability as scaffolds for cell culture by ionic
crosslinking with divalent cations such as Ca2+ [122]. Widespread applicability of alginate
hydrogels has been extended to culturing different cell types, both in vivo and in vitro. Alginate is
a linear naturally derived polysaccharide from seaweed and is composed of (1,4)-linked β-dmannuronate (M) and α-l-guluronate (G) residues in varying contents and distributions along the
polymer [122]. Alginate can be more readily crosslinked as more G residues are present in the
molecule along increasing Ca2+. Benefits of alginate hydrogels are gelation at physiological
conditions, transparency for microscopic evaluation, and retention of a homogenous, porous
network formation that allows diffusion of nutrients and removal of waste [122].
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We adopted an alginate-based hydrogel system [117] that was used to generate bulk threedimensional scaffolds with biomechanical properties that mimicked various developmental and
disease states in cardiac tissues, namely embryonic (soft), physiological (normal) and fibrotic
(stiff) states. Human AC16 cardiomyocytes were cultured in these three distinct gels of varying
mechanical properties, and the resulting differences in morphology, intercellular network
formation, and cardiac-specific protein expression profile were compared. We hypothesized that
cardiomyocytes in stiffer scaffolds would express altered behavior, including reduced cell
spreading, elongation, and network formation when compared to cells cultured in softer scaffolds.
Results from this study should reveal important information about the regulation of cardiomyocyte
cell behavior in response to mechanical variances in the extracellular microenvironment. By
modulating the surrounding scaffold stiffness, we expected to identify physiological changes in
the cultured cardiomyocytes which may be recapitulative of cardiac disease or fibrosis in-vivo.
Furthermore, it was expected that results would also give insight into material selection and
consideration of mechanical properties when engineering three-dimensional cardiac tissues invitro.
6.3. MATERIALS AND METHODS
6.3.1. Materials
Medium viscosity alginate (MVG alginate) with high guluronic acid content along the
molecular backbone of the polymer (Nova Matrix, Norway), was used to create three distinct
hydrogels of varying elastic moduli. Guluronic acid content in alginate is responsible for its
crosslinking, and thus this material was used as the stiffness could be more readily modulated. The
modified alginate was mixed with Matrigel Matrix (Corning Inc., Corning, NY, USA) to provide
points of cell adhesion within the crosslinked gels, as alginate does not contain any RGD or other
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amino acid sequences that provide a point of attachment for cells [123]. According to the
manufacturer, the alginate has greater than 60% G character. Calcium carbonate ( CaCO3; Fisher
Scientific, Fair Lawn, NJ, USA) and d-(+)-gluconic acid δ-lactone (GDL; Millipore Sigma, St.
Louis, MO) were used as crosslinking agents. A buffer solution was created with sodium chloride
(NaCl; Fisher Scientific, Fair Lawn, NJ, USA) and 1 M HEPES buffer solution (Fisher Scientific,
Fair Lawn, NJ, USA) to dissolve the components.
Alginate immediately reacts when exposed to divalent cations such as Ca2+. This
spontaneous crosslinking causes nonhomogeneous gel formation. We have attempted to better
control these ionic effects by adopting a method where free divalent calcium ions are introduced
in a controlled manner to create more homogenous gels [117, 124]. Insoluble CaCO3 and
hydrolysable GDL release free Ca2+ ions by lowering the pH in solution [117]. A time-delayed
release of calcium ions, results in the formation of homogenous alginate gels within 1 h. Molar
concentration of GDL was always 3.5 times that of CaCO3 to maintain a neutral pH. This range
of concentration for CaCO3 and GDL has been reported to be well tolerated by cells in other
studies [117]. Cells were mixed with the alginate solution before gelation to ensure a uniform
distribution throughout the gel.
6.3.2. Optimization of Hydrogels
In order to find concentrations of both crosslinker and polymer that would resemble the
mechanical properties found in the three heart stiffnesses of interest mentioned in Section 6.1,
different concentrations of MVG alginate gels (4, 7, and 10% w/v) were each crosslinked with
three different calcium carbonate concentrations (10, 30, and 50 mg/mL). The hydrogels that were
formed were then subjected to rheological analysis to determine their elastic modulus. The results
of this optimization procedure were plotted and a quadratic line was found to best fit the data using
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MATLAB, as seen in Figure 6.1. A “fibrotic” gel was synthesized with 50 mg/mL of calcium
carbonate and 10% (w/v) MVG alginate as it produced the stiffest hydrogel from all trials. Next,
because “physiologic” stiffness’s in the heart are seen to be between 9-10 kPa, a value of 9.5 was
used for the y-variable in the quadratic equation for the 7% alginate, and its appropriate coefficients
were used to solve for the optimum amount of calcium carbonate needed to produce gels of that
stiffness. The same procedure was done with the 4% alginate quadratic equation and coefficients
to produce an “embryonic” gel with a stiffness from 1-3 kPa. The final calculated and optimized
concentrations of alginate and crosslinker to produce the three hydrogels used in the main study
can be referenced in Table 6.1. The values for GDL were then calculated by keeping the same ratio
of CaCO3 to GDL as described in other studies [117].

Figure 6.1: Three concentrations of MVG alginate (4, 7, 10 % w/v) were each cross-linked with
three different concentrations of calcium carbonate (10, 30, 50 mg/mL) and fitted
with a quadratic equation in order to find optimum polymer and crosslinking
concentrations that produce hydrogels with varying degrees of stiffness. This figure
was taken with permission from [37]
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6.3.3. Gel Formulation
Alginate gels of varying stiffness were created, as described in Table 6.1. To create 1 mL
of bulk hydrogel, 250 μL Matrigel was mixed with 400 μL of an alginate solution in Table 6.1 and
vortexed to for homogeneity. After vortexing, 100 μL of 300 mM NaCl in 1 mM HEPES buffer
was then added to the alginate mixture and vortexed once again to further dissolve any unmixed
reagents. To create a dilute crosslinking solution, 100 μL of the buffer was mixed separately with
50 μL calcium carbonate and 50 μL GDL.
For cell culture studies all solutions were sterile-filtered using 0.2 μm filters (Aerodisc LC
25 mm, PALL Life Sciences, Ann Arbor, MI, USA), while alginate solutions were autoclaved.
Cardiomyocytes were seeded into the alginate-Matrigel mixture into a 24-well plate before adding
the crosslinking solution into the wells to ensure the cells were encapsulated within the hydrogel.
Cell mixture represented 5% of the total gel volume (50 μL). Gels used for material
characterization were crosslinked without the addition of cells.
Table 6.1: Concentrations of alginate, calcium carbonate, and GDL are shown for embryonic,
physiologic, and fibrotic gels
1 mL
Embryonic
Physiologic
Fibrotic

400 μL
4% (w/v)
MVG Alginate
7% (w/v)
MVG Alginate
10% (w/v)
MVG Alginate

50 μL
17.45 mg/mL
CaCO3
45.35 mg/mL
CaCO3
50 mg/mL
CaCO3

50 μL
62.21 mg/mL
GDL
161.4 mg/mL
GDL
177.9 mg/mL
GDL

200 μL
300 mM + 1 mM
HEPES buffer
300 mM + 1 mM
HEPES buffer
300 mM + 1 mM
HEPES buffer

250 μL
Matrigel

50 μL
Cell suspension

Matrigel

Cell suspension

Matrigel

Cell suspension

6.3.4. Rheology
The mechanical stiffnesses of alginate gels were analyzed by conducting small oscillatory
measurements on an Anton-Paar MCR 101 rheometer (Anton-Paar, Graz, Austria) with an 8 mm
parallel plate configuration that performed oscillatory shear stress sweeps of 1% strain at
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frequencies from 0.5 to 50 Hz. The values for moduli were taken at 1.99 Hz for all groups, and the
elastic modulus was determined by the storage and loss moduli obtained for all samples using:
𝐸 = (1 + 𝑣) 𝑥 𝐺.
In the above formula, G is the modulus of rigidity or shear modulus, E is the elastic
modulus, and ν is Poisson’s ratio [117]. Before rheometric analysis, gel samples were processed
by cutting a cylindrical punch of about 8 mm in diameter and 1 mm in thickness and were allowed
to swell in 1X PBS for 12 h.
6.3.5. Scanning Electron Microscopy
Average pore diameter of the embryonic, physiologic, and fibrotic gels was determined by
analyzing electron micrographs of cross-sectioned lyophilized samples [47]. For SEM imaging,
uniform-sized bulk gel discs were lyophilized and sputter-coated with gold/palladium (2–3 min)
in a sputter coater (Gatan Model 682 Precision etching coating system, Pleasantown, CA, USA)
and visualized using SEM (S-4800, Hitachi, Japan) at voltages of 12–15 kV at varying
magnifications. Collected images obtained were analyzed using Image J to determine the average
pore diameter of each distinct gel type as done before [47].
6.3.6. Swelling Analysis
Hydration and the swelling behavior of the gel scaffolds were assessed using a swelling
assay. Samples were allowed to swell to equilibrium for up to 48 hr in Dulbecco Modified Eagle’s
Medium (DMEM without Ca2+, pH 7, 25 °C) following published protocols [47]. All gels samples
were crosslinked and stored at − 80 °C overnight and then freeze dried using a VirTis BenchTop
Pro Freeze Dryer with Omnitronics (SP Scientific, Warminster, PA, USA). The weights of the dry
lyophilized samples were recorded (W0) and then immersed in DMEM. Swollen hydrogel weights
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(Wt) were documented at 1 h intervals for 8 hours and then at the 24th and 48th hour. Swelling ratio
was calculated using the following equation where Ds is the degree of swelling:
𝐷" = D

𝑊# − 𝑊$
E 𝑥100
𝑊$

6.3.7. Three-Dimensional Cell Culture in Bulk Hydrogels
AC16 human cardiomyocyte cell lines (CM, Millipore cat no. SCC109) were cultured in
Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham (DMEM/F-12) (Sigma, cat no.
D6434, St. Louis, MO, USA) supplemented with 12.5% fetal bovine serum (FBS), 2 mM Lglutamine, and 1X penicillin–streptomycin as reported in Chapter 3 and henceforth referred to as
the complete growth medium [47]. L-glutamine is an essential amino acid used in cell culture that
can be used as an energy source by dividing cells [125]. It further serves as a nitrogen source for
cells to synthesize nucleic acids, proteins, and the like [125]. Other additives in the media include
sodium pyruvate as an extra energy and carbon source, glucose, and HEPES buffer, according to
the vendor. A more detailed description of the AC16 cell line and media can be referenced in
Chapter 2. Media was changed every two days, and cells were passaged before reaching
confluence.
To visually track cells within crosslinked gels, CM were pre-stained with PKH26, a red
fluorescent general membrane staining dye (Sigma), as done before [47]. CM were mixed into the
bulk gels (i.e. embryonic, physiologic, fibrotic) before crosslinking to ensure homogeneity within
the wells. These cell-gel constructs were cultured for 4 and 7 days (with complete growth medium,
37 °C, 5% CO2), after which these samples were imaged without fixation using confocal
fluorescence microscopy (Zeiss). Matrigel (Corning) coated 2D wells were used as controls. A
total of 1×106 cells/well were seeded in 3D bulk alginate samples, and 1×105 cells/well for 2D
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controls in 24-well plates. At days 4 and 7, images were acquired from the cells cultured within
gels, and aspect ratio calculations were performed using similar protocols used in literature [117]:
𝐴𝑠𝑝𝑒𝑐𝑡 𝑅𝑎𝑡𝑖𝑜 =

𝑤𝑖𝑑𝑡ℎ 𝑜𝑓 𝑐𝑒𝑙𝑙
ℎ𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑐𝑒𝑙𝑙

6.3.8. Cell Viability
To determine viability of cells encapsulated in all gel types, a Live/Dead assay (Thermo
Fisher Scientific, Waltham, USA) was implemented at 5 days of culture. Calcein AM that stained
the live cells green, and Ethidium homodimer that stained the dead cells red, respectively. After 5
days of culture, the cell-laden constructs were subjected to the Live/Dead assay. All images
collected were analyzed using quantitative image analysis through Image J. The percentage of live
or dead cells were calculated using:
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =

# 𝑔𝑟𝑒𝑒𝑛 (𝑙𝑖𝑣𝑒)𝑜𝑟 𝑟𝑒𝑑 (𝑑𝑒𝑎𝑑)𝑐𝑒𝑙𝑙𝑠
𝑥100
𝑡𝑜𝑡𝑎𝑙 # 𝑜𝑓 𝑔𝑟𝑒𝑒𝑛 + 𝑟𝑒𝑑 𝑐𝑒𝑙𝑙𝑠

6.3.9. Statistical Analysis
All characterizations and experiments were performed in triplicates. Data in this study is
presented as the mean ± standard deviation. In order to determine if the means of three independent
datasets were statistically significant, a one-way ANOVA with a post-hoc Tukey’s multiple
comparison test was used for evaluation. P-values where p < 0.05 were considered statistically
significant.
6.4. RESULTS AND DISCUSSION
6.4.1. Embryonic, Physiologic, and Fibrotic Alginate Gels
Optimized alginate gels of three distinct stiffnesses were achieved as shown in Figure 6.1
by changing monomer or crosslinking reagent concentration. Rheological analysis found the
average storage modulus was always greater than the loss modulus for all three gel formulations.
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This signaled the alginate gels experienced more solid-like properties than liquid-like. Three
hydrogel formulations (Table 6.1) were selected to simulate embryonic, physiologic, and fibrotic
environments pf the heart. High guluronic acid content made the gels more readily crosslinkable
to achieve these values. Gels deemed embryonic were found to have an elastic modulus of 2.66 ±
0.84 kPa, physiologic with 8.98 ± 1.29 kPa, and fibrotic with 18.27 ± 3.17 kPa. These values were
all significantly different from one another with p < 0.05. While physiologic and fibrotic scaffolds
were significantly different from one another, an almost two-fold difference between their stiffness
may not be optimal to studying the effects of cellular behavior, thus potentially introducing a
limitation to our study [126]. Future work will focus on further enhancing the difference in stiffness
between experimental groups.
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Figure 6.2: The average storage, loss, and elastic moduli of three distinct bulk alginate gels are
graphically depicted (A). Crosslinking density of gels increases by increasing either
monomer or crosslinking agent concentration (B). This figure was taken with
permission from [117].
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6.4.2. Average Pore Size and Hydration Behavior of Three Gels
Visual inspection of electron micrographs for all three gel types revealed a porous and
interconnected architecture essential for culturing cells. Porous gels allow for gas exchange and
the delivery of nutrients to cells. Representative SEM images of embryonic, physiologic, and
fibrotic gels are displayed in Figure 6.3A-C. Average pore diameter (Figure 6.3D) was calculated
to be 51.2 ± 2.8 μm for embryonic, 38.4 ± 15.9 μm for physiologic, and 32.3 ± 9.1 μm for fibrotic
gels, respectively, with a significant difference p < 0.05. As shown by these results, the average
pore diameter decreases with stiffness, which is also reported by another group (Annabi et al.
2010).
Hydration behavior of all three gels were assessed in DMEM to further characterize the
material properties of the scaffolds. Swelling assay results can be referenced in Figure 6.3E.
Embryonic gels, the softest of all three, swelled to a greater extent, while stiffer fibrotic gels,
appeared to swell the least. Since swelling behavior is dependent on the extent of polymer
crosslinking [127], these results could imply that the fibrotic scaffolds were crosslinked to a greater
degree due to their increased alginate and CaCO3 content, with respect to the physiological and
embryonic scaffolds. Swelling data was analyzed through a Two-Step Anova and corroborated
with a Post Hoc Honestly Significant Difference Tukey test, pointing towards a very highly
significant difference in swelling ratio (p < 0.01) observed in the embryonic scaffold. Physiologic
and fibrotic scaffolds showed almost no statistical difference between their swelling rates. Unlike
covalently crosslinked hydrogels, alginate crosslinks are reversible and when exposed to aqueous
media [128]. During swelling, it leads to the leaching out of the Ca2+ ions into the culture media
from the scaffolds initiating their disintegration.
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Figure 6.3: Material characterization of three alginate gels shows an interconnected, porous
structure (A-C). Average pore size decreases with increasing stiffness (D). Swelling
decreases as stiffness increases (E), This figure was taken with permission from
[37].
6.4.3. Cellular Reaction to Mechanical Environment
Fluorescent images of cells forming networks within embryonic, physiologic, and fibrotic
gels were acquired at 4 days and 7 days, respectively, as shown in Figure 6.3. Visual inspection
between the two measurement timepoints, qualitatively confirmed cell proliferation in all three gel
types. Another observation appeared to show longer shape in cells in softer gels, that rounded as
stiffness increased. To confirm this, aspect ratio calculations were performed on cells within each
gel. A higher aspect ratio suggested longer morphology, rather than rounded. Average aspect ratio
for cells in embryonic gels was highest with a significant difference of p = 0.02. As stiffness
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increased, the average aspect ratio trended toward a rounded cell morphology, There was,
however, no significant difference between cells in physiologic and fibrotic gels.

Figure 6.4: PKH26-stained cardiomyocytes in all three cell types showed signs of proliferation
from 4 days to 7 days in culture. Cells in softer 3D bulk gels showed a longer
morphology and a higher degree of networking as compared to the other
progressively stiffer 3D bulk gels. This figure was taken with permission from [37].
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6.4.4. Confirmation of Network Formation
Representative bright field microscopic images from all gel samples show cardiomyocyte
network formation after a week of culture as shown in Figure 6.5. Average number of networks
formed within the cultures was calculated for each gel. We defined a network to be a coupled
pattern within a group of adjacent cells. Embryonic gels displayed a significantly higher number
of networks. Network formation was seen to decrease with increasing stiffness. In embryonic gels,
cells were capable mechanical deformation of the matrix to form extensions into the gels. As the
gels were progressively stiffened, the cells’ ability to remodel the matrix was diminished, and the
cells appeared predominantly rounded, since the matrix was relatively stiffer to deform or because
the degradation sites were obstructed by the introduction of additional crosslinks [117].
Cellular network behavior was confirmed by human AC16 cells cultured atop Matrigelcoated 2D wells. When Matrigel was excluded from the gels, no networks were evident after 5
days of culture in all gels, although the cells retained viability and depicted cluster formation as
shown in Figure 6.6. This is because alginate alone does not contain any cell-adhesion moieties
for cells to elongate themselves [123].
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Figure 6.5: Brightfield microscopic images at 7 days of culture show CM cellular networking in
embryonic, physiologic, and fibrotic 3D bulk gel types. Networking decreases with
increasing stiffness. This figure was taken with permission from [37]
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Figure 6.6: Florescent microscopic image of PKH26-stained AC16 CM show clustered, rounded
cells in alginate gels without the inclusion of Matrigel. Without RGD adhesion
moieties, these cells cannot elongate. This figure was reproduced with permission
from [37]
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6.4.5. Cell Viability
Live/Dead assay was performed after 5 days in culture to assess cell viability within the
three different gels. Cardiomyocytes cultured within embryonic gels showed greater viability
amongst the other with 89 ± 10% live cells and 11 ± 10% dead cells. As gel stiffness increased,
viability decreased. Physiologic-cultured cells had 71 ± 15% live cells with 29 ± 15% dead cells,
while fibrotic gels had 61 ± 13 live cells with 39 ± 13% dead cells within their respective scaffolds.
Representative fluorescent microscopic images of live cells represented by the green color emitted
by Calcein AM, diminishes as stiffness increases in Figure 6.7. Furthermore, the dead cells stained
by Ethidium Homodimer is seen to increase with increasing stiffness of the gel. There was a
significant difference (p < 0.05) between the number of live to dead cells in both the embryonic
and physiologic-mimicking scaffolds; however, no such significance was seen in the fibrotic
scaffold. Furthermore, there was a significant difference in the percentage of viable and dead cells
between the embryonic and fibrotic scaffolds. Decrease in cell viability could possibly be due to
the smaller pore size in fibrotic gels whose purpose are to allow cellular migration and diffusion
of gasses and nutrients. Implications of this data can be extrapolated to explain why grafts in the
zone of dense collagen deposition after myocardial infarction led to reduced cell engraftment
compared to softer grafts [129].
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Figure 6.7: Live/Dead assay after 5 days of culture reveals a decrease in cardiomyocyte viability
as the stiff-like character of the gel increased. Live cells are stained green by
calcein AM, while dead cells are stained with ethidium homodimer-1 which
fluoresces red. This figure was taken with permission from [37]
6.5. CONCLUSION
In this study, the stiffness of alginate hydrogels was modulated by changing the
crosslinking density. We adopted a dynamically tunable system using alginate hydrogels to study
how it affects cellular morphology and network formation in cardiac myocytes [117]. By doing
so, we were able to develop three distinct gel stiffness that mimicked values found during
embryonic, physiologic, and fibrotic states of the extracellular matrix of the native heart. By
culturing cardiomyocytes within these different mechanical environments, we hypothesized this
would yield important insights into normal tissue development and also pathological modulation
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of disease progression in cardiac tissue. It was found that cells within softer gels our 3D system
experienced extensive cell spreading, elongation, and network formation. Our system is cell
compatible and is responsive to modeling dynamic phenomena, such as tissue fibrosis, to isolate
the effects of matrix stiffening. We used this static system to demonstrate the regulation of CM
morphology by matrix mechanical in all gels.
The variable gel stiffness’s resulted from the guluronic regions in the alginate backbone
that were physically crosslinked in the presence of divalent cations and the variable calcium
concentration. This platform well suited for 3D cell encapsulation experiments, as cell viability
was maintained across all gels, and changes in cell morphology were revealed in response to
stiffening. We have demonstrated that matrix stiffness has a specific and important role in the
formation of such cardiac cell networks, which are essential toward cardiomyocyte function and
behavior and modulation of disease pathology. This study forms the basis for the utilization of a
dynamically tunable substrate to study how the upregulation of matrix ECM stiffness can result in
loss of cell function, as may be the case in cardiac fibrosis or cardiomyopathy. The system is
simple yet unique as it allows reversible stiffening or softening to model cell behavior as needed.
In addition to increasing the difference in stiffness between our scaffolds, future studies
will explore the ability to dynamically control the gel stiffness, both spatially and temporally.
Attempt to modulate the stiffness of these alginate substrates in real time to study their effects on
cardiac cell cultures, including a combination of cardiomyocytes, cardiac fibroblasts, and
endothelial cells will be made. Thus, it will be possible to translate in-vitro outcomes to more
relevant in vivo disease models. Furthermore, converting this hydrogel system into a 3Dbioprintable one will allow us to create even more physiologically and pathophysiologically
relevant tissue structures that further recapitulate processes that occur in native tissues.
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Chapter 7: Conclusion and Closing Remarks
Heart disease remains the greatest contributor to morbidity and mortality around the world.
As such, there exists a dire biomedical need for new ways to cure, treat, and study this disease.
Tissue engineering using three-dimensional bioprinting offers a powerful avenue to design
biologically-mimetic and geometrically-relevant cardiac tissues of the native heart. These tissues
can be used for a wide array of biomedical applications including: as grafts, pharmaceutical
discovery and testing, and disease modeling, amongst others. In this dissertation, the development
and characterization of various scaffolds have been elucidated that hold promise in designing
cardiac tissues in-vitro.
In Chapter 3, a novel bioink consisting of fibrin and a modified gelatin was employed to
bioprint a cardiac patch that was architecturally similar to heart tissue, showed excellent
biocompatibility, and afforded coupling of two major cardiac cell types. With potential of this
construct to be used as a graft to treat myocardial infarction patients, a method for inducing a lesion
on the heart of an animal model using cryoinjury was adopted in Chapter 4. Cryo-infarction can
be used as an alternative method to produce a zone of necrotic tissue in a reproducible manner,
which could be beneficial to control during implantation studies. Chapter 5 laid the foundation for
further optimization of a scaffold that would support endothelial cells as the third major cell type
found in the heart to study microgravity-induced hypertrophy. The addition of ECs is to provide a
more complete cell model for the study of cardiac diseases. Finally in Chapter 6 the importance
of three-dimensional hydrogel mechanical properties and their effect on cardiac cells gave insight
to how stiffness of the ECM alters CM physiology. These results do not only give understanding
about disease modulation during fibrosis, but has implications in choosing the appropriate
mechanical properties of hydrogels used to bioprint viable and cardiac-mimetic tissues in-vitro.
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As implied by the title, this dissertation has gone over various methods and points to
consider when engineering cardiac tissues using three-dimensional bioprinting. These tissues can
be further developed and optimized to be implemented for a variety of biomedical applications.
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